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1. Introduction 
Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are worldwide avian pathogens 
of significant economic importance (Raviv and Ley, 2013). MG and MS are known to be 
associated with respiratory and synovial infections like chronic respiratory disease (CRD) in 
chicken, infectious sinusitis in turkeys and infectious synovitis (Ferguson and Noormohammadi, 
2013; Raviv and Ley, 2013). Lately, MS has also been reported to be associated with new 
syndromes like eggshell apex abnormalities (EAA) (Feberwee et al., 2009) as well as the layer E. 
coli peritonitis syndrome (EPS) in layers (Raviv et al., 2007b).  
Definite MG/MS diagnosis with genotype identification represents the first step for subsequent 
successful control measurements. Many techniques have been described for MG and MS 
diagnosis that is based on detection of the pathogen (through pathogen cultivation or molecular 
detection) and or specific antibodies (through serological tests) (OIE, 2008).  
Cultivation of MG and MS is laborious, expensive, time consuming and can be unsuccessful 
(Kleven, 2008a). On the other hand, the commonly used serological tests are usually hindered 
by lack of specificity and/or sensitivity (OIE, 2008). Molecular detection of MG and MS 
represented rapid, accurate, complementary or even alternative diagnostic tool for cultivation 
and serological tests.  
For MG and MS typing, methods like random amplified polymorphic DNA (RAPD), pulsed field 
gel electrophoresis (PFGE), amplified fragment length polymorphism (AFLP), restriction 
fragment length polymorphism (RFLP) and DNA sequencing have been described. However, 
some problems associated with low reproducibility and inability for inter laboratory data 
exchange have been reported with RAPD (Hong et al., 2005b). PFGE and AFLP proved good 
discriminatory power but they are time consuming, laborious and require purified genomic DNA 
(Champion et al., 2002). Sequencing of single and multiple gene portions known as gene-
targeted sequencing (GTS) showed robust typing capability for MG and MS (El-Gazzar et al., 
2012; Ferguson et al., 2005). Sequencing offered also the possibility for typing of uncultivable 
pathogens, as well as inter laboratory data exchange (Armour et al., 2013; Bayatzadeh et al., 
2014; Ferguson et al., 2005; Gharaibeh et al., 2011). 
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On the other hand, the role of free-ranging birds in MG/MS transmission and epidemiology has 
not been extensively studied except through relatively few studies. Some of these studies 
focused mainly on MG with less attention toward MS (Gharaibeh and Hailat, 2011). Others were 
experimentally applied and lacked the natural infection conditions (Dhondt et al., 2008; 
Gharaibeh and Hailat, 2011; Kleven and Fletcher, 1983). As far as our knowledge, none of these 
studies investigated infecting MG/MS strains originating from free-ranging birds down to the 
subspecies level (Farmer et al., 2005; Luttrell et al., 2001; Stallknecht et al., 1998).  
Herein during the first part of study, we investigated MG and MS infection in 104 poultry flocks 
by isolation as well as MG and MS species-specific PCR. The genetic profile of occurring MG and 
MS strains was investigated and compared by genotyping. MG genotyping was carried out 
through restriction fragment length polymorphism of phase-variable putative adhesin (pvpA-
RFLP) and multiple gene-targeted sequencing (GTS) analysis of portions of the MG cytadhesin 2 
(mgc2) gene, pvpA gene and MG 16S-23S intergenic spacer region (IGSR). MS genotyping was 
carried out through sequencing of the conserved portion of variable lipoprotein and 
hemagglutinin A (vlhA) gene. AFLP technique was also applied for typing of cultivable MG and 
MS. The discriminatory capability of each typing method was estimated and compared to 
explore the most appropriate method. The relationship between German and global MG and 
MS strains published in GenBank was also investigated. 
Through the second part of study, we investigated MG and MS originating from two naturally 
infected chicken farms as well as from the contacting free-ranging birds within each farm. MG 
and MS originating from both hosts were genotyped and compared. MG strains were compared 
through multiple GTS analysis of mgc2 gene, pvpA gene and MG 16S-23S IGSR. For MS, the 
conserved portion of vlhA gene was sequenced and compared. 
 
      
 
3 
 
2. Literature 
2.1. Historical overview 
The first probable isolation of Mollicutes was in 1898 by Nocards and Roux from a cattle 
showing signs of contagious bovine pleuropneumonia, from which the ‘’Pleuropneumonia 
like organisms (PPLO)’’ name was given. However, the first report on avian Mycoplasma was 
by Dodd in 1905 in England who described sinusitis in turkeys and termed it as “epizootic 
pneumoenteritis of the turkeys” (Lancaster and Fabricant, 1988).  
‘’Infectious coryza of chickens’’ was the term given in 1935 for describing a slow and long 
lasting coryza and this was probably the first case of Chronic respiratory disease (CRD) in 
chicken (Nelson, 1935; Raviv and Ley, 2013). However, the term ‘’chronic respiratory 
disease’’ (CRD) was first given by Delaplane and Stuart (1943) for the clinical manifestations 
of the disease in chicken. Dickinson and Hinshaw (1938) introduced the term “infectious 
sinusitis” to describe the disease in turkeys (Lancaster and Fabricant, 1988). 
The first description of infectious synovitis associated with Mycoplasma was in 1954 and 
1956 (Olson et al., 1954; Olson et al., 1956). The respiratory form and air sac infection has 
been reported in cases of M. synoviae combination with ND and IB vaccines (Olson et al., 
1964a; Olson et al., 1964b). 
2.2. Biology and taxonomy of Mycoplasma  
The genus Mycoplasma belongs to the class Mollicutes (in Latin, mollis, soft; cutis, skin). The 
name ‘’Mollicutes’’ refers to the nature of these organisms that lack the bacterial cell wall 
known in other bacteria. Mycoplasmas are surrounded by just a trilaminar membrane 
(Bradbury, 2005; Razin et al., 1998). Mycoplasmas are the smallest free living eubacteria 
possessing the smallest genome (0.58 – 2.2 Mbp) with low G+C content (23 – 40 mol %). 
The genome of Mycoplasmas lacks even the genetic data required for a cell wall synthesis. 
Lack of cell wall renders Mycoplasma resistant to antibiotics affecting cell wall synthesis like 
penicillin which is usually incorporated in cultivation medium to control other bacterial 
growth  (Razin and Herrmann, 2002).  
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The genus Mycoplasma contains more than 200 identified species infecting a wide range of 
hosts including human, animals, plants and insects 
(http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi). From animal Mycoplasma, 
more than 20 species are known to infect avian hosts. Mycoplasma gallisepticum (MG) and 
Mycoplasma synoviae (MS) are the most clinically relevant avian Mycoplasmas (Raviv and 
Ley, 2013). 
2.3. Mycoplasma gallisepticum 
MG is the most pathogenic avian Mycoplasma species with significant economic impact as 
one of the costliest diseases confronting poultry industry worldwide (Raviv and Ley, 2013). 
Infection with MG is commonly known as chronic respiratory disease (CRD) in chickens and 
infectious sinusitis (IS) in turkeys. MG infection is characterized by respiratory 
manifestations and frequently swelling in infraorbital sinuses in turkeys (Raviv and Ley, 
2013). Another form of MG infection was observed in American house finches that 
experienced severe conjunctivitis (Delaney et al., 2012; Ley et al., 1996). 
The impact of MG on egg production was studied, where MG-infected flock produced 12 
fewer eggs per hen than uninfected flock. MG F-strain-vaccinated hens produced 6 eggs 
more than unvaccinated infected hens. Losses in commercial layer flocks in Southern 
California were estimated to be approximately 127 million eggs due to MG. Egg production 
losses in association with costs of  MG control programs were approximately $7 million 
(Mohammed et al., 1987). 
Pathogenesis starts with the attachment of MG to host epithelial cells. This attachment has 
been shown to be mediated through capsular structures (blebs or tip structures) on the 
outer surface of the Mycoplasma membrane responsible for cytadsorption to chicken 
tracheal epithelium (Bencina, 2002; Tajima et al., 1982). Like for many other Mycoplasmas, 
MG epithelial colonization is followed by epithelial invasion and dysfunction. Complications 
due to infection with other pathogens or due to environmental factors exaggerate the MG 
infection (Kleven, 2008a).   
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The genome of several MG strains including virulent and attenuated strains is about 1 Mbp 
(Papazisi et al., 2003; Szczepanek et al., 2010). The first published complete MG genome 
sequence was from a MG R_low passage reference strain that revealed 996 422 bp with 31 
mol% G+C content and demonstrated two copies of the rRNA and 33 tRNA genes (Papazisi 
et al., 2003). Genomes of the attenuated high-passage MG R strain, as well as of MG F, ts-11 
and 6/85 vaccine strains, were also published (Szczepanek et al., 2010).  
In addition to killed vaccine, live MG vaccines like F, ts-11 and 6/85 vaccine strains have 
been used for MG control programs in different countries (Jacob et al., 2014). 
Differentiation between MG field and vaccine strains has always been a matter of challenge 
for many researchers, especially with the increasing usage of live MG strains for vaccination 
nowadays (Ghorashi et al., 2015; Raviv et al., 2008).    
2.4. Mycoplasma synoviae 
Exudative synovitis, tendovaginitis, or bursitis are different forms of MS infection due to 
involvement of synovial membranes of joints and tendon sheaths preceded by systemic MS 
infection (Ferguson and Noormohammadi, 2013). Infections with MS are mostly subclinical 
and not clinically apparent until complicated with other pathogens like Newcastle disease 
virus (NDV) and or infectious bronchitis virus (IBV) causing air sac lesions. 
Lately, MS has been associated with a new form of infection known as eggshell apex 
abnormalities (EAA). Alteration in shell surface, shell thinning with cracks and breaks 
occurrence are the characteristics of the new infection form (Feberwee et al., 2009). Also, 
involvement of MS in development of E. coli peritonitis syndrome (EPS) in layers has been 
reported (Raviv et al., 2007b). 
The complete genome sequence of MS has been published (May et al., 2015; Vasconcelos 
et al., 2005). Analysis of MS genomes (strain 53) demonstrated the identity of several 
genome segments between M. synoviae and M. gallisepticum and the possibility for 
horizontal gene transfer between both pathogens (Papazisi et al., 2003; Vasconcelos et al., 
2005). 
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2.5. Diagnosis 
Diagnosis of MG and MS is based on the detection of the pathogen and/or of specific 
antibodies. Detection of MG and MS pathogens is carried out through cultivation and or 
species-specific nucleic acid detection using molecular tools like PCR. Serological tests like 
serum plate agglutination tests (SPA), hemagglutination inhibition (HI) or enzyme-linked 
immunosorbent assay (ELISA) are tests used for the detection of MG and MS specific 
antibodies (Kleven, 2008b; OIE, 2008). 
2.5.1. Cultivation and identification 
M. gallisepticum and M. synoviae are relatively fastidious micro-organisms that require 
protein rich medium usually enriched with serum or serum factors (Kleven, 2008a). MG and 
MS ferment glucose which is also added to the growth medium. MS requires extra addition 
of Nicotinamide adenine dinucleotide (NAD) (Kleven, 2008b).  
Similar to other Mycoplasmas, MG and MS are resistant to antibiotics affecting cell wall 
synthesis and are partially resistant to thallium acetate. Penicillin (2,000 IU/ml) and thallium 
acetate (up to 1:2.000) are added to the growth medium to control other bacterial and 
fungal contamination. Phenol red is added to the broth medium as indicator for growth and 
pH changes, e.g. MG and MS ferment glucose leading to acid formation that lowers the pH 
and the colour of the phenol red indicator changes from red to orange/yellow (Bradbury, 
1998; OIE, 2008).   
Several laboratory and commercial liquid and agar media are known to be used for MG/MS 
isolation, e.g. Frey medium (Frey et al., 1968), SP-4 medium (Bradbury, 1977; Bradbury, 
1998), PPLO medium (Kleven, 2008b) and medium offered by Mycoplasma Experience, 
Reigate, Surrey, United Kingdom.  
Optimal growth of MG and MS is usually achieved at 37°C with 5% CO2 and high humidity. 
MG and MS colonies are usually seen after 3–5 days post incubation, however some isolates 
may take longer. Growth of fastidious isolates may require 2 or 3 serial passages with 5-7 
days intervals. Direct plating of exudates or tissue swabs onto Mycoplasma agar may result 
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in colonies after 4–5 days of incubation, but initial culture in broth followed by agar plates 
inoculation has been reported to be more sensitive for isolation (Kleven, 2008b). 
Typical Mycoplasma colonies are small (about 0.1—1.0 mm), circular with elevated centre 
giving the ‘fried egg’ appearance on solid medium, however it might not be seen with some 
Mycoplasmas. Overgrowth of non-pathogenic Mycoplasma like M. gallinarum and M. 
gallinaceum on MG or MS is known, especially in samples of multiage layers (Kleven, 
2008b).  
MG and MS colonies could be identified by direct or indirect immune-fluorescence (IF), 
immuno-peroxidase (IP), immuno-binding assay or growth inhibition test using species-
specific antibodies (OIE, 2008; Rosendal and Black, 1972; Talkington and Kleven, 1983). 
In spite of considering cultivation as a standard for infection diagnosis, slow growth and the 
fastidious nature of MG and MS that might take up to 3-4 weeks as well as the frequent 
overgrowth by non-pathogenic Mycoplasma, represent critical obstacles hindering the wide 
applicability MG and MS cultivation in practice. 
2.5.2. Serological tests 
Many serological tests have been described for the detection of MG and MS specific 
antibodies. From these tests, serum plate agglutination (SPA), the hemagglutination-
inhibition (HI) and Enzyme-linked immunosorbent assays (ELISA) are the mostly used (OIE, 
2008). 
The SPA test is a simple, quick, and inexpensive test for the detection of MG and MS 
antibodies. It is carried out by mixing equal amounts of tested serum sample and stained 
MG or MS antigen. Antigens for MG and MS are commercially available. The SPA test has 
efficient sensitivity because it detects mainly the early produced immunoglobulin after 
infection, the IgM antibodies (Kleven, 1975) however, its main disadvantage is the low 
specificity. Cross reactions and false positive results are known to occur with test 
application. Cross reactions between MG and MS, recently vaccinated birds with oil-
emulsion vaccines as well as media components included through antigen preparation are 
causes for SPA false positive reactions (Glisson et al., 1984; Kleven, 2008b; Yoder, 1989).  
      
 
8 
 
On the other hand, the hemagglutination-inhibition (HI) is more specific compared to the 
SPA test, but some obstacles hinder its wide usage like the laboriousness, time 
consumption, and unavailability of reagents needed on the commercial scale (Kleven, 
2008b; Kleven et al., 1988). The main disadvantages of the HI test are the inability to detect 
antibodies of variant MG strains and the low sensitivity as it might not detect antibodies 
before 3 weeks post infection. This is because the HI test detects the lately produced 
immunoglobulins, the IgG antibodies (Talkington and Kleven, 1983).  
Enzyme-linked immunosorbent assays (ELISA) were developed to improve the sensitivity of 
the hemagglutination-inhibition test and the specificity of serum plate agglutination tests. 
Beside many available commercial ELISA kits for the detection of MG and MS, laboratory 
developed ELISA assays have also been described (Higgins and Whithear, 1986; Opitz et al., 
1983). 
In order to improve specificity of ELISA, MG and MS species specific proteins were purified 
and cloned to be used for coating ELISA plates (Buyuktanir et al., 2008; Noormohammadi et 
al., 2002a; Noormohammadi et al., 2002b; Noormohammadi et al., 1999). Multiplex ELISAs 
detecting MG, MS and M. meleagridis have also been described (Ben Abdelmoumen 
Mardassi et al., 2008).   
The efficiency of culture and PCR was compared with serological tests (SPA, HI and ELISA) 
for the detection of MG. PCR and culture showed comparable results and were better than 
serological tests. Different degrees of false positive results with most of the serological tests 
were demonstrated. A combination of more than one diagnostic tool for definite MG 
diagnosis was recommended (Feberwee et al., 2005b). 
Generally, high frequency of antigenic variability experienced by MG and MS isolates, cross 
reaction between MG and MS and other pathogens, interference with oil-emulsion vaccines 
and medications have been reported as reasons for false positive results achieved by 
serological tests (Kleven, 2008b). Therefore, MG and MS serological tests are recommended 
as screening tests rather than being definite diagnostic tests. Flocks with positive serological 
results should be confirmed by other methods like pathogen isolation and molecular 
detection of the infecting pathogen (Raviv and Ley, 2013). 
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2.5.3. Molecular diagnosis and identification 
Introduction of molecular techniques to the MG and MS diagnostic represented an 
important shift. Accuracy, time saving, and cost effectively of molecular techniques made 
them to complementary or even alternative for conventional diagnostic methods. 
In early research works, DNA probes were widely used for MG and MS diagnosis (Dohms et 
al., 1993; Fernandez et al., 1993; Geary, 1987; Geary et al., 1988; Khan et al., 1987; Santha 
et al., 1987; Zhao and Yamamoto, 1990). Afterwards, PCR represented a safer, more 
accurate and applicable alternative that avoids the harmful effect of radiolabeled probes 
with better sensitivity and easier applicability. Improvements for sensitivity and specificity 
of conventional PCR took place with the introduction of new modifications like semi-nested, 
nested, multiplex, real-time and TaqMan probe PCRs. 
2.5.3.1. PCR for MG diagnosis  
Species-specific PCRs for MG were firstly developed in the nineties of the last century. The 
earlier PCR trial used Amp-L and Amp-R primers and produced a 732 bp amplicon. This PCR 
showed positive results with nucleic acid of 16 MG strains and isolates, while negative 
results were shown with DNA of 16 avian Mycoplasmas other than MG as well as with E. 
coli, lambda phage, pUC8 plasmid and calf thymus (Nascimento et al., 1991). Two years 
later, the MGF-PCR that differentiated MG F vaccine strain from other MG strains was 
developed. MGF-PCR used MGF-P1 L and MGF-P1R primers and amplified a 524  bp  product 
with MG F-strain only (Nascimento et al., 1993). 
By the middle of 1990s and with the advances in sequencing and utilization of 16S rRNA 
nucleotide sequence as a basis for bacterial taxonomy, other MG species-specific PCR 
assays based on MG 16S rRNA gene sequence were developed (Kempf et al., 1993; 
Lauerman, 1998). The new PCR assays proved to be sensitive and specific for MG detection, 
where MG species-specific PCR tested positive with 70 out of 72 tracheal swabs collected 
from MG experimentally infected specific pathogen free (SPF) chickens (Kempf et al., 1993). 
Combination of PCR with restriction fragment length polymorphism (RFLP) analysis (PCR-
RFLP) was used to detect and differentiate MG, MS, M. iowae and M. meleagridis , however 
it did not differentiate between MG and M. imitans (Fan et al., 1995b). Another PCR-RFLP 
      
 
10 
 
amplified the Mycoplasma specific 16S rRNA sequence by PCR using common primers to 
avian Mycoplasmas followed by restriction of the amplified product using restriction 
enzymes. Species identification is based on the restriction pattern. The new PCR was 
specific (could differentiate between MG, MS and M. imitans) and sensitive (100 
Mycoplasmas detection capability). 
With the identification of the MG specific cytadhesin-like protein MGC2, a PCR based on the 
mgc2 gene was developed (Hnatow et al., 1998). Combination of PCR targeting the mgc2 
gene with restriction of the amplified product (PCR-RFLP) was able to differentiate between 
some MG strains like MG 6/85 and ts-11 vaccine strains (Lysnyansky et al., 2005). 
The specificity and sensitivity for four MG-PCRs (16S rRNA PCR, mgc2-PCR, the nested LP-
PCR and gapA-PCR) were compared. The lowest specificity was shown with the 16S rRNA 
PCR that amplified DNA from both MG and M. imitans, whereas mgc2-, nested LP-, and 
nested gapA PCRs amplified DNA from MG only. The sensitivity of the PCRs of 16S rRNA and 
mgc2, nested LP, and nested gapA were estimated at 40, 40, 400 and 4 color-changing units 
(CCU)/amplification reaction, respectively. Based on the sensitivity and specificity results as 
well as the time turnaround, the mgc2-PCR seemed to be the most promising among the 
PCR methods investigated (Garcia et al., 2005).  
Lierz and coauthors developed and evaluated species-specific PCR for detection of MG. The 
newly developed MG-PCR together with other species–specific assays for the differentiation 
of MS, M. meleagridis, M. imitans and M. iowae were used and evaluated for the detection 
of the respective pathogens in birds of prey (Lierz et al., 2008b). PCR sensitivity for MG, MS, 
M. meleagridis, M. imitans and M. iowae were high and were 0.1, 1, 10, 0.1 and 0.1 pg of 
genomic DNA, respectively. 
Sensitivity of a new qualitative real-time polymerase chain reaction (Q-PCR) for M. 
gallisepticum detection was evaluated. The Q-PCR showed 10 to 1000 times better 
sensitivity than conventional PCR and culture. The Q-PCR showed good specificity with most 
important avian Mycoplasmas like MS and M. meleagridis, however, it could not distinguish 
between MG and Mycoplasma imitans (Mekkes and Feberwee, 2005).  
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Another real-time PCR assay differentiating between MG strains including the F, ts-11, and 
6/85 vaccine strains has been described (Raviv et al., 2008). Also a combination of the 
TaqMan probes technology with real-time PCR for identification of the four common 
poultry Mycoplasmas, MG, MS, M. meleagridis and M. iowae has been reported. Sensitivity 
of the new PCR was 1 copy for MG and 10 copies for MS, M. meleagridis and M. iowae 
(Raviv and Kleven, 2009).  
2.5.3.2. PCR for MS diagnosis  
Similar to MG and based on the availability of 16S rRNA sequence of the M. synoviae, 
species-specific MS-1 (5'-GAAGCAAAATAGTGATATCA-3') and MS-2 (5'-
GTCGTCTCCGAAGTTAACAA-3') primers were selected and utilized for MS species-specific 
PCR. This PCR showed 100% specificity with an estimated sensitivity of 100 colony-forming 
units (Lauerman et al., 1993). Afterwards, this MS-PCR design was modified by addition of 
two nucleotides at the 5’ end of the primer to improve specificity. Through clinical samples, 
this modified MS-PCR showed higher sensitivity than culture and detected 17 MS samples. 
However, only 7 samples out of 27 total samples were detected by culture (Marois et al., 
2000).  
Another PCR for MS was developed by pairing a primer complementary with the 16S-23S 
intergenic spacer region with a primer from the 23S rRNA gene (Ramirez et al., 2006). This 
PCR was sensitive (1.15 pg DNA detection) and tested positive with 21 MS field isolates, 
while negative with 22 other avian mycoplasmas. 
A new PCR assay using primers complementary to the single-copy end of the variable 
lipoprotein and haemagglutinin gene (vlhA) of MS was developed. The new PCR (vlhA-PCR) 
amplified approximately 400 bp and showed good degree of MS intra-species discrimination 
(Jeffery et al., 2007). Due to high degree of sequence variation in the vlhA gene, new revised 
degenerating primers were designed to improve sensitivity of the vlhA-PCR. This revised 
vlhA-PCR amplified approximately 300 bp of the single-copy end of the vlhA gene and 
showed better sensitivity (Wetzel et al., 2010).  
A duplex PCR assay based on the pMGA and vlhA haemagglutinins for the detection of MG 
and MS, respectively, in one reaction was described (Mardassi et al., 2005; Pflaum et al., 
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2016). The assay showed enough specificity and sensitivity for simultaneous detection of 
MG and MS field isolates (Mardassi et al., 2005). Also a duplex real-time PCR assay using 
TaqMan probes and including internal controls (duplex MGMS PCR) for MG and MS 
detection has been described (Sprygin et al., 2010b). The new duplex MG-MS PCR showed 
high specificity and a sensitivity of 1 and 7 cfu/ml for MS and MG, respectively. 
2.6. MG and MS typing 
2.6.1. MG typing by Sequencing of partial genes 
MG has surface-exposed cytadhesins known as haemagglutinins. These haemagglutinins 
express phase and size variability, and they are immunogenic as well (Bencina, 2002; Razin 
et al., 1998). MG haemagglutinins are variable lipoproteins encoded by up to 70 genes. 
Other cytadhesins like PvpA, Mgc2 and Mgc1 proteins are also expressed by MG but they 
are encoded as single copy in the MG genome. High degree of phase variation in gene and 
proteins of the surface integral membrane protein of MG (the pvpA) gene has also been 
documented (Yogev et al., 1994). 
Molecular characterization of the Mycoplasma gallisepticum cytadhesin 2 (mgc2) gene and 
protein revealed differences between MG strains (Hnatow et al., 1998). Amplification of the 
mgc2 gene of the MG 6/85 vaccine strain by PCR produced a characteristic amplicon that 
differed from other MG strains (Garcia et al., 2005; Kleven et al., 2004). Moreover, 
restriction of the mgc2-PCR amplicon with HaeII and SfaN1 restriction enzymes known as 
the restriction fragment length polymorphism (mgc2-PCR-RFLP) technique could 
additionally differentiate MG ts-11 vaccine strains from other MG strains (Lysnyansky et al., 
2005).  
Boguslavsky and coauthors characterized an integral surface expressed membrane protein, 
the PvpA protein, that included high proline content in the C-terminus of the amino acid 
sequence  with two identical copies of 52 amino acids sequences designated direct repeat 1 
(DR1) and direct repeat 2 (DR2) sequences (Boguslavsky et al., 2000). 
Differences in pvpA gene sequences between MG strains were the basis for the usage and 
development of restriction fragment length polymorphism of pvpA gene (pvpA-RFLP) as well 
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as pvpA sequences alignment and comparison (Ferguson et al., 2005; Liu et al., 2001; Pillai 
et al., 2003). 
PvpA-RFLP included amplification of the variable putative cytadhesin protein pvpA gene by 
PCR followed by restriction of the amplicon using restriction endonucleases (Liu et al., 
2001). PvpA-RFLP could distinguish 7 different genogroups within 66 MG isolates (Pillai et 
al., 2003). PvpA-RFLP together with other MG genome fragments have been also used to 
differentiate the MG live vaccine strain F from other MG strains like MK-7, MS-16, R , S6 and 
FS-9 strains (Biro et al., 2006).  
Sequencing of other MG gene segments like the MG 16S-23S intergenic spacer region (IGSR) 
was also evaluated as a tool for MG genotyping. Some reports described that the 16S-23S 
intergenic spacer region is a helpful tool for Mycoplasma inter species differentiation 
(Ramirez et al., 2008; Volokhov et al., 2006). However, other studies reported a good 
discriminatory power of 16S-23S intergenic spacer region as a tool for MG intra-species 
differentiation and considered it as a promising tool for epizootiological studies (Gharaibeh 
et al., 2011; Raviv et al., 2007a).  
On the other hand, sequencing of single target gene segments like the pvpA, mgc2, and 
gapA genes has been used as a basis for MG strains typing and discrimination (Hong et al., 
2005b; Khalifa et al., 2014; Pillai et al., 2003; Raviv et al., 2007a; Sprygin et al., 2010a).  
Combination of sequencing results of multiple segments of the MG genome like pvpA, 
mgc2, gapA and MG 16S-23S IGSR known as multiple gene-targeted sequencing (multiple 
GTS) proved high discriminatory capability between MG strains (Ferguson et al., 2005; 
Gharaibeh et al., 2011; Ghorashi et al., 2013). Multiple GTS proved also comparable typing 
results to those of whole genome finger printing techniques like RAPD and AFLP. Extra 
advantages of multiple GTS like higher reproducibility, typing of uncultivable Mycoplasma 
isolates and the ability of inter-laboratory data exchange have been reported (Ferguson et 
al., 2005; Gharaibeh et al., 2011). Trials to create a database for MG genotyping on the basis 
of multiple GTS have been described (Armour et al., 2013; Ghorashi et al., 2013).  
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2.6.2. MS typing by Sequencing of partial genes 
Genomes of MS encode some proteins known as haemagglutinins that show high degree of 
variation between strains and isolates. The variable lipoprotein haemagglutinin A gene 
(vlhA) is one of those haemagglutinins. VlhA of MS are lipoproteins encoded by vlhA gene 
and pseudogene (Bencina, 2002; Noormohammadi, 2007).The VlhA of MS reveals a high 
degree of variability between strains (Noormohammadi et al., 2000). Nucleotide sequence 
variation of the vlhA of MS has been the basis for MS genotyping (Bayatzadeh et al., 2014; 
Dijkman et al., 2014; El-Gazzar et al., 2012; Hong et al., 2004; Jeffery et al., 2007; Ramirez et 
al., 2011; Wetzel et al., 2010).  
The vlhA gene of MS is widely used for MS typing in many countries (Bayatzadeh et al., 
2014; Dijkman et al., 2014; Ogino et al., 2011). Because of the high degree of variation in 
the vlhA gene between MS strains, different primers sequences for improving the vlhA 
amplification efficiency have been described (Hammond et al., 2009; May and Brown, 2011; 
Ogino et al., 2011; Wetzel et al., 2010).  A PCR design amplifying approximately 400 bp of 
the MS-vlhA gene was developed in 2007 (Jeffery et al., 2007). Also a revised vlhA-PCR using 
degenerating primers and amplifying approximate 300 bp of the MS-vlhA gene was 
established (Wetzel et al., 2010). The revised vlhA-PCR assay showed better sensitivity than 
other PCRs and could overcome the problem of false negative results (300 pm).  
In a recent study, the discriminatory power of the vlhA gene and the AFLP were compared. 
Comparable clustering of investigated MS strains was described, in spite of detection of 
minor differences between both methods (Dijkman et al., 2014).  
The potential capability of the MS 16S-23S intergenic spacer region (IGSR) was investigated 
for MS strains differentiation. The heterogeneity of the two copies of the 16S-23S IGSR of 
MS limited its wide use for MS typing. This heterogeneity necessitated the inclusion of a 
cloning system which is not available for all laboratories (Ramirez et al., 2011). 
Although the vlhA gene is yet the only gene available for MS genotyping, trials for utilization 
of other MS gene segments or other techniques are research focus for many scientists. This 
should enable definite, robust MS strains differentiation. 
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2.6.3. Whole genome fingerprinting techniques  
Different whole genome typing techniques like random amplified polymorphic DNA (RAPD), 
restriction endonuclease analysis (REA), pulsed-field gel electrophoresis (PFGE) and the 
amplified fragment length polymorphism (AFLP) have been described for MG and MS 
typing.  
The RAPD technique is based on utilization of random primers for amplification of purified 
genomic DNA. The RAPD technique produced characteristic electrophoretic profiles with 
MG strains that markedly differed from those of MS, M. gallinarum and M. iners using the 
same arbitrary primers (Geary et al., 1994). Another RAPD assay with different arbitrarily 
primers was developed and could differentiate and group 25 MG strains and isolates 
according to the electrophoretic pattern on agarose gels (Fan et al., 1995a).  
Efficiency of RAPD technique and pulsed-field gel electrophoresis (PFGE) was compared for 
MG and MS strains typing. The two techniques showed comparable results and could 
differentiate MG strains from the M. imitans strains. Low reproducibility of RAPD as well as 
the laboriousness and time demand and low typeability of PFGE were the drawbacks of 
these techniques (Harada et al., 2009; Marois et al., 2001; Mettifogo et al., 2006). 
The AFLP is based on amplification of selective restriction fragments. AFLP assay includes 
digestion of genomic DNA with restriction endonucleases followed by ligation of specific 
adapters according to restriction sequences. Afterwards, ligated fragments are amplified by 
PCR using fluorescent-labeled primers and PCR amplicons are separated onto a 
polyacrylamide gel. The AFLP was evaluated for characterization of 50 strains of human and 
animal mycoplasmas. AFLP showed high discriminatory power with reproducible AFLP 
electrophoretic patterns that included 60 to 80 fragments ranging from 50 to 500 bp 
(Kokotovic et al., 1999). 
The discriminatory capability of the RAPD technique and the AFLP for MG and MS 
differentiation was compared. AFLP showed higher discriminatory capability than the RAPD 
technique for MG and MS genotyping (Feberwee et al., 2005a; Hong et al., 2005a; Hong et 
al., 2005b). AFLP offers the advantage of combination of segmenting the genomic DNA 
using specific restriction enzymes together with amplification of restricted genomic DNA by 
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PCR. This combination allows better resolution of electrophoretic patterns and more bands 
allowing better discrimination between isolates (Hong et al., 2005a; Savelkoul et al., 1999).  
2.7. Host range of MG and MS 
MG and MS spread horizontally by direct and indirect contact with infected birds. Vertical or 
trans-ovarian transmission through eggs plays a significant role in the epidemiology and 
spread of MG and MS (Armour and Ferguson-Noel, 2015; Raviv and Ley, 2013). 
Contaminated feeders and drinkers with infected fomites have been also reported to 
transmit MG bacteria (Dhondt et al., 2007). 
The natural hosts for MG and MS are the gallinaceous birds, especially chickens and turkeys. 
For a long time, Mycoplasmas were considered as host-specific pathogens (Razin et al., 
1998), but in the meantime many reports describe the same Mycoplasma species to infect 
different hosts (Bradbury, 2005).  
MG has been isolated from natural infections in ducks (Bencina et al., 1988a), geese (Buntz 
et al., 1986), song birds (Morishita et al., 1999) as well as from chukar partridges, pheasants, 
and peafowl (Cookson and Shivaprasad, 1994). Also MS has been isolated from natural 
infection cases in birds other than chicken and turkey like pigeon (Bencina et al., 1987; 
Reece et al., 1986), ducks (Bencina et al., 1988a), and geese (Bencina et al., 1988b). 
Moreover, an emergence of a novel MG strain in American house finches (Carpodacus 
mexicanus) in the 1990s has been described (Ley et al., 1997; Ley et al., 1996; Luttrell et al., 
2001). The new emerging disease resulted in epidemics of severe conjunctivitis in American 
house finches with estimated hundreds of millions of population losses in few years after 
the first wave of disease (Delaney et al., 2012; Dhondt et al., 2005; Ley et al., 1996). House 
sparrows and budgerigars have been experimentally infected with MG and MS and the 
respective pathogens were reisolated (Bozeman et al., 1984; Gharaibeh and Hailat, 2011; 
Kleven and Fletcher, 1983), however infected birds seemed less susceptible to infection as 
they did not show disease manifestations. 
Also, some studies investigating the incidence, susceptibility and role of Mycoplasma in 
different bird categories have been described (Farmer et al., 2005; Hartup et al., 2001; Lierz 
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et al., 2007; Lierz et al., 2008a; Lierz et al., 2008b; Lierz et al., 2000; Poveda et al., 1990), 
where different Mycoplasma species were detected in new hosts. However, none of these 
studies investigated or compared infecting Mycoplasma pathogens from new hosts down to 
the sub species level. 
On the other hand, reports describing threats of emerging diseases caused by free-ranging 
birds, like avian influenza A virus, West Nile virus infection and other infections, are 
increasing. So that, more attention has to be directed towards investigation of the role 
played by such birds in disease epidemiology (Staley and Bonneaud, 2015). 
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3. Materials and Methods 
3.1. Samples 
3.1.1. Samples investigated during the first part of study 
Five hundred fifteen Swabs (tracheal, pharyngeal, choanal, lung, synovial and phallus) were 
collected from 104 different bird flocks (Table 1). These flocks represented cases showing 
clinical signs of Mycoplasma infection (respiratory, locomotor disorders or fertility troubles). 
Some flocks originated from the same farm but from different occasions. 
Table 1: List of samples investigated through first part of study including their identity number, 
sample type, actual number of birds sampled and some notes concerning case history when 
available.   
  
Entry number 
(Flocks) 
animal species Sample type 
No. of 
swabs 
1 632/11/TK Turkey breeders Tracheal swab 10 
2 774/11/CK Chicken Tracheal swab 10 
3 824/11/TK Turkey breeders Tracheal swab 5 
4 884/11/PH Pheasant Synovial fluid 1 
5 898/11/Tit Blue and grey tits Choanal swab 82 
6 920/11/CK Chicken Tracheal swab 1 
7 940/11/CK Chicken Tracheal swab 1 
8 982/11/GS Goose Phallus swab 3 
9 985/11/TK Turkey breeders Tracheal swab 2 
10 998/11/GS Goose Tracheal swab 1 
11 1001/11/CK Chicken Tracheal swab 3 
12 1074/11/CK Chicken Tracheal swab 10 
13 1105/11/TK Turkey breeders Tracheal swab 3 
14 1233/11/CK Chicken Tracheal swab 2 
15 1255/11CK Chicken Tracheal swab 1 
16 1321/11/CK Chicken Tracheal swab 5 
17 1470/11/CK Chicken Tracheal swab  2 
18 1478/11/TK Turkey tracheal swab 1 
19 1482/11/CK Chicken tracheal swab 3 
20 1571/11/CK Chicken tracheal swab 1 
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21 1601/11/TK Turkey Tracheal swabs & synovial fluid 1 
22 1608/1/11/TK Turkey breeders Mycoplasma colonies on agar plates 1 
23 1608/2/11/TK Turkey breeders Mycoplasma colonies on agar plates 1 
24 1608/3/11/TK Turkey breeders Mycoplasma colonies on agar plates 1 
25 1608/4/11/TK Turkey breeders Mycoplasma colonies on agar plates 1 
26 1608/5/11/TK Turkey breeders Mycoplasma colonies on agar plates 1 
27 1608/6/11/TK Turkey breeders Mycoplasma colonies on agar plates 1 
28 1608/7/11/TK Fattening turkey Mycoplasma colonies on agar plates 1 
29 1608/8/11/TK Fattening turkey  Mycoplasma colonies on agar plates 1 
30 1732/11/CK Chicken Tracheal swab 1 
31 1750/11/CK Chicken Tracheal swab 1 
32 1808/11/CK Chicken Tracheal swab 1 
33 1861/11/CK Chicken Tracheal swab 1 
34 1887/11/TK Turkey Tracheal swab 3 
35 1909/11/CK Chicken Tracheal swab 1 
36 1931/11/CK Chicken Tracheal swab 1 
37 1965/11/CK Chicken Tracheal swab 2 
38 2020/11/PH Pheasant Tracheal swab 1 
39 2038/11/CK Chicken Tracheal swab 1 
40 2042/11/TK Turkey synovial fluid 4 
41 2072/11/CK Chicken Tracheal swab 3 
42 2081/11/CK Chicken Tracheal swab 1 
43 2141/11/TK Turkey Tracheal swab 3 
44 2192/11/CK Chicken Tracheal swab 1 
45 2464/11/CK Chicken Tracheal swab 1 
46 2539/11/CK Chicken Tracheal swab 1 
47 2636/11/CK Chicken Tracheal swab 1 
48 2730/11/TK Turkey breeders Tracheal swab 12 
49 24/2012/TK Turkey breeders Tracheal swab 24 
50 187/12/TK Turkey breeders Tracheal swab 25 
51 279/12/PG Turkey breeders Tracheal swab 10 
52 417/12/TK Turkey Tracheal swab in Mycoplasma medium 6 
53 499/12/TK Turkey  Tracheal swab in Mycoplasma medium 1 
54 561/12/TK Turkey breeders Tracheal swab 6 
55 720/12/ZF Zebra finches Choanal & pharyngeal swabs 19 
56 797/12/CK Chicken Tracheal and synovial swabs  7 
57 904/12/TK Turkey breeders Tracheal swab 2 
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58 1567/12/CK Chicken Tracheal swab 4 
59 1786/12/CK Chicken Tracheal swab 22 
60 1858/12/CK Chicken Tracheal swab 10 
61 1885/12/CK Chicken Tracheal swab 11 
62 1905/12/SW Swan Tracheal swab 1 
63 1906/12/CK Chicken Tracheal swab 1 
64 1907/12/CK Chicken Tracheal swab 2 
65 1936/12/CK Chicken Tracheal swab 1 
66 2122/12/CK Chicken Tracheal swab 2 
67 2124/12/CK Chicken Tracheal swab 1 
68 2187/12/CK Chicken Tracheal swab 1 
69 2207/12/CK Chicken Tracheal swab 2 
70 2208/12/CK Chicken Tracheal swab 4 
71 2286/12/CK Chicken Tracheal swab 9 
72 2312/12/PH Pheasant Tracheal swab 1 
73 2453/12/CK Chicken Tracheal swab 2 
74 2348/12/TK Turkey Synovial fluid 10 
75 19/13/CK Chicken Tracheal swab 2 
76 154/13/CK Chicken Tracheal swab 1 
77 209/13/CK Chicken Tracheal swab 1 
78 342/13/CK Chicken Tracheal swab 1 
79 364/13/CK Chicken Tracheal swab 6 
80 370/13/CK Chicken Tracheal swab 1 
81 516/13/PG Pigeon Trachea & Air sacs swabs 1 
82 612/13/CK Chicken Tracheal swab 2 
83 649/13/TK Turkey Tracheal swab 2 
84 833/13/CK Chicken Tracheal swab 13 
85 925/13/CK Chicken Tracheal swab 4 
86 1088/13/TK Turkey Tracheal swab 2 
87 1233/13/CK Chicken Tracheal swab 10 
88 1372/13/CK Chicken Tracheal swab 2 
89 1554/13/CK Chicken Tracheal swab 1 
90 1561/13/CK Chicken Tracheal swab 1 
91 1847/13/CK Chicken Tracheal swab 2 
92 1911/13/CK Chicken Tracheal swab 2 
93 2054/13/CK Chicken Tracheal swab 2 
94 2087/13/CK Chicken Tracheal swab 1 
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Sample description: entry number/year of sampling/bird species.  
For bird species: CK = chicken; GS= Goose; PH=Pheasants; SW= Swan; Tit= Blue and grey tits; TK 
= turkey and ZF=Zebra finches 
*samples 1608-1/11/TK and 1608-2/11/TK were isolated in 2006 and 2007, respectively, but 
were investigated during this work. 
 
3.1.2. Samples investigated during the second part of study 
During the second part of the study, chickens and contacting free-ranging birds from areas of 
two organic chicken farms (farm I and farm II).  Chickens and contacting free-ranging birds were 
simultaneously sampled over 3 days. 
In farm I, Lohmann brown layers were reared, however, in farm II, Lohmann brown layer 
breeders were kept. Contacting free-ranging birds were trapped using mist nets built in the free-
ranging areas in both farms. The permission No. 39.80.02.40-2013/01 39.3 B/rl, RP Giessen, 
Giessen federal office authority was obtained before trapping free-ranging birds. Tracheal 
swabs were collected from chickens, while oro-pharyngeal swabs were collected from free-
ranging birds. Captured free-ranging birds we released after sampling and trimming a small part 
from tail feathers to avoid resampling.  
Samples collected from farm I are; 
a- 20 tracheal swabs from chicken. 
b- 70 pharyngeal swabs from house sparrows (Passer domesticus).  
c- 3 pharyngeal swabs from blue tits (Parus caeruleus).  
d- 1 pharyngeal swab from black bird (Turdus merula).  
 
95 2251/13/CK Chicken Tracheal swab 10 
96 2554/13/CK Chicken Tracheal swab 1 
97 2591/13/CK Chicken Tracheal swab 2 
98 77/14/CK Layer chickens Tracheal swab 20 
99 96/14/CK Chicken Tracheal swab 10 
100 171/14/CK Chicken Tracheal swab 1 
101 331/14/CK chicken Tracheal swab 20 
102 374/14/PH Pheasant Tracheal and Lung swabs 11 
103 600/14/CK Chicken Tracheal swab 1 
104 1073/14/CK Chicken Tracheal and Lung swabs 2 
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Samples collected from farm II are;  
a. 20 tracheal swabs from chicken.  
b. 43 pharyngeal swabs from house sparrows (Passer domesticus). 
c. 1 pharyngeal swab from black bird (Turdus merula).  
3.2. Devices for Mycoplasma cultivation 
Sanyo CO2 incubator Sanyo, München 
Light microscope Carl Zeiss, Oberkochen 
pH meter  Mettler-Toledo, Schwerzenbach 
Fine Balance Denver Instrument, Göttingen 
Filter membrane Sartorius, Göttingen 
0.22 and 0.45 µm syringe filter membrane Millex®HA, Millipore, Carrigtwohill, Ireland 
Sterile petri dishes Sartorius, Göttingen 
Sterile plastic tubes Sartorius, Göttingen 
Lamina Flow Class II Nunc, Wiesbaden 
3.3. Chemicals for Mycoplasma cultivation medium (SP4 broth and SP4 agar 
medium) 
1) PPLO Broth: BD Biosciences, Heidelberg 
2) Bacto agar: BD Biosciences, Heidelberg 
3) Swine serum: PAA Laboratories, Pasching, Austria 
Heat inactivated at 56°C for 45 minutes in water bath, aliquoted into 50 ml, and stored at -
20°C till use. 
4) Fresh yeast preparation: Commercial yeast powder 
250 g commercial dried yeast were dissolved in distilled water till 1000 ml total volume. 
This suspension was boiled in a boiling water bath for 30 min. It was then cooled and 
centrifuged at 3000 g for 30 min. The supernatant was taken, sterilized by filtration through 
0.45 µm filter, aliquoted into 50 ml, and stored at -20°C till use. 
5) Nicotinamide Adenine dinucleotide (NAD): Sigma-Aldrich, Munich 
1% NAD solution was prepared by dissolving 0,5 g NAD in 50 ml distilled water. The solution 
was sterilized by filtration through a 0.45 µm filter (Millex®HA, Millipore, Carrigtwohill, 
Ireland), aliquoted into 5 ml, and stored at -20°C till use. 
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6) Glucose: Merck, Darmstadt 
10% Glucose solution was prepared by dissolving 10 g glucose in distilled water till 100 ml 
total volume. The solution was sterilized by filtration through 0.45 µm filter, aliquoted into 
10 ml, and stored at -20°C till use. 
7) Arginine: Merck, Darmstadt 
10% Arginine solution was prepared by dissolving 10 g arginine in distilled water till 100 ml 
total volume. The solution was sterilized by filtration through 0.45 µm filter, aliquoted into 
10 ml, and stored at -20°C till use. 
8) Ampicillin: Merck, Darmstadt 
1% Ampicillin solution was prepared by dissolving 1 g ampicillin in distilled water till 100 ml 
total volume. The solution was filtrated through a 0.45 µm filter, aliquoted into 10 ml, and 
stored at -20°C till use. 
9) Penicillin G sodium: Roth, Karlsruhe 
A solution of Penicillin G sodium 100 000 IU/ml was prepared by dissolving 10 000 000 
Unites of Penicillin G sodium in distilled water till 100 ml total volume to give a solution of 
100,000 units per ml. The solution was filtered through a 0.45 µm filter, aliquoted into 10 
ml, and was stored at -20°C till use. 
10) Thallium acetate: Roth, Karlsruhe 
5% Thallium acetate solution was prepared by dissolving 5 g Thallium acetate in distilled 
water till 100 ml total volume. The solution was filtrated through a 0.45 µm filter, aliquoted 
into 10 ml, and stored at -20°C till use. 
11) Phenol red: Roth, Karlsruhe 
0.1% Phenol red solution was prepared by dissolving 0.1 g of phenol red powder in 2,8 ml of 
0.1 M NaOH. This mixture was made up to 100 ml with double distilled water to make 0.1% 
solution and autoclaved at 121°C for 20 minutes, aliquoted into 10 ml, and then stored at -
20°C. 
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3.3.1. SP4 broth medium preparation (1000 ml) (Bradbury, 1998)   
Part A 
PPLO broth  14.7 g 
Distilled water  700 ml 
Part B 
Swine serum (heat inactivated) 150 ml 
Fresh yeast extracts (25% solution) 100 ml 
Nicotinamide adenine dinucleotide (NAD) (1% solution) 10 ml 
10% Glucose solution (10% solution) 10 ml 
10% Arginine solution (10% solution) 10 ml 
Penicillin (100 000 U/ml) 10 ml 
Ampicillin (1% solution) 10 ml 
Thallium acetate (5% solution) 10 ml 
Phenol red (0.1 % solution) 20 ml 
 Part A is autoclaved at 121 °C for 20 minutes and then kept at 50°C in water bath. 
 Components of part B were aseptically mixed together and added to part A. 
 PH is then adjusted to 7.4 with 1 M NaOH. Prepared medium is distributed in 1,8 ml aliquots 
in sterile 6 ml plastic tubes and kept at 4°C for up to 6 months. 
3.3.2. SP4 agar medium preparation (1000 ml) (Bradbury, 1998)   
 Part A 
Difco PPLO broth  14.7 g 
Bacto agar  10 g 
Distilled water  700 ml 
 Part B 
Swine serum (heat inactivated) 150 ml 
Fresh yeast extracts (25% solution) 100 ml 
Nicotinamide adenine dinucleotide (NAD) (1% solution) 10 ml 
10% Glucose solution (10% solution) 10 ml 
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10% Arginine solution (10% solution) 10 ml 
Penicillin (100 000 U/ml) 10 ml 
Ampicillin (1% solution) 10 ml 
Thallium acetate (5% solution) 10 ml 
 Part A is autoclaved at 121 °C for 20 minutes and kept at 50°C in water bath. 
 Components of part B were aseptically mixed together and warmed to 50°C in water bath 
and was then added to part A. 
 Prepared agar medium is distributed in sterile 4 cm petri dishes and kept at 4°C for up to 6 
months. 
 Each newly prepared SP4 broth and SP4 agar was tested for sterility and growth efficiency 
for MG and MS strains.   
3.4. Mycoplasma cultivation procedures (Bradbury, 1998) 
Mycoplasma cultivation procedures were carried out using SP4 broth and SP4 agar as described 
(Bradbury, 1998). Tracheal (or pharyngeal) swabs were taken into fresh SP4 broth, vortexing, 
and swabs were taken out from broth and kept at - 80°C.  
Inoculated broth was 10 fold serially diluted till 10-3 in fresh SP4 broth. Original and diluted 
broths were inoculated on SP4 agar plates. Inoculated broth and agar were incubated at 37°C 
and 5 % CO2 with high humidity. Color changes of broth and appearance of Mycoplasma 
colonies on agar plates (detected under light microscope) were daily evaluated for the first 5 
days and then every 2 days for up to 4 weeks. Incubated broth was subcultured onto fresh broth 
and agar plates directly (in case of broth color change) or every week (in case no broth color 
change was observed).   
In case of Mycoplasma colonies’ appearance, 3 single colonies (almost morphologically 
different) were immediately picked and taken onto fresh SP4 broth. Purification of colonies was 
done by filtration through a 0.45 µm filter membrane and passages onto fresh SP4 broth and 
agar. This process was repeated for 3 times for complete isolate purification. Pure clones were 
kept at -80 °C till further processing. 
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3.5. Chemicals and devices for DNA extraction 
DNeasy Blood & Tissue Kit QIAGEN, Hilden 
QIAcube automatic machine for DNA extraction                                  QIAGEN, Hilden 
Nano Drop spectrophotometer         Thermo Scientific, Braunschweig 
Thermo mixer Comfort Eppendorf, Hamburg 
Absolute alcohol                             Roth, Karlsruhe 
Dulbecco’s PBS PAA Laboratories, Pasching, Austria 
 
3.6. DNA extraction 
DNeasy Blood & Tissue Kit (QIAGEN, Hilden, Germany) was used for DNA isolation according to 
the manufacturer’s instructions with little modifications according to sample type.  
3.6.1. DNA extraction from Mycoplasma cultured broth  
In case of successful Mycoplasma cultivation onto SP4 media, DNA was extracted from cultured 
broth. One ml of cultured broth was centrifuged at 21.000 g for 10 minutes. Pellets were twice 
washed with sterile PBS before suspension in 100 µl PBS. Twenty µl of proteinase K were added 
to resuspended pellet. Two hundred µl of Buffer AL (lysis buffer) were added, thoroughly mixed 
by vortexing, followed by incubation at 56°C for 10 minutes. Two hundred µl of absolute alcohol 
were added and thoroughly mixed by vortexing. The whole mixture was pipetted onto DNeasy 
Mini spin column placed in a 2 ml collection tube.  
The column was centrifuged at 6000 g for 1 min and the flow-through was discarded. The 
column was placed in a new 2 ml collection tube. Five hundred μl of Buffer AW1 (washing buffer 
1) were added to the column followed by centrifugation for 1 min at 6000 g, and the flow-
through was discarded. Five hundred μl of Buffer AW2 (washing buffer 2) were added to the 
column followed by centrifugation for 3 min at 20.000 g, and the flow-through was discarded. 
The DNeasy Mini spin column was then placed in a clean 1.5 ml eppendorf tube. One hundred μl 
Buffer AE (elution buffer) were pipetted onto the column membrane, incubated at room 
temperature for 1 min, and then centrifuged for 1 min at 6000 g. Steps from addition of 
proteinase K till elution were manually done or automatically by QIAcube automatic machine. 
DNA concentration was measured by Nano Drop spectrophotometer (Thermo Scientific, 
Braunschweig, Germany) and DNA was frozen at -20 °C till examination.  
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3.6.2. DNA extraction from collected swab samples 
In case of unsuccessful Mycoplasma cultivation or cultivation of Mycoplasma other than MG or 
MS, DNA was extracted directly from collected swab samples. Cotton tip of swabs were 
aseptically cut and taken into a sterile 1.5 ml eppendorf tube.    
Three hundred fifty µl of sterile PBS were added to the cotton tip of swab followed by thorough 
pipetting or vortexing. One hundred µl of the PBS suspension were taken into fresh 1.5 ml 
eppendorf tube.  
The following steps from addition of proteinase K, Buffer AL, absolute alcohol, washing, elution 
and freezing of eluted DNA were done as above mentioned with DNA extraction from 
Mycoplasma culture.  
3.7. Chemicals and devices for polymerase chain reaction (PCR) 
DreamTaq DNA polymerase master mix  (10 X Dream Taq Buffer 
contains KCL and (NH4)2SO4 and 20 mM MgCl2) 
Thermo Scientific, 
Braunschweig 
HotStarTaq Master Mix (10 X HotStar Taq Buffer contains Tris·Cl, 
KCl, (NH4)2SO4, 15 mM MgCl2) 
QIAGEN, Hilden 
dNTPS Mix (2 mM each) PEQLAB Biotechnologie, 
Erlangen 
Water, nuclease free QIAGEN, Hilden 
TPersonal 48 thermocycler          Biometra, Göttingen 
Oligonucleotide primers   Biomers, Ulm 
3.8. Genus Mycoplasma PCR (Lierz et al., 2007) (modified from (van Kuppeveld et al., 
1992) 
Generally, the PCRs of the present study were performed using ready mixed Master Mixes; 
DreamTaq DNA polymerase master mix or HotStarTaq Master Mix, according to the 
manufacturer’s instructions. PCR reaction master mix contained 2.5 µl 10 X Dream Taq Buffer, 
dNTP Mix, forward and reverse primers, Taq polymerase and template DNA. PCR reaction 
master mix was completed to 25 µl with nuclease free water. Thermal programs were carried 
out in the TPersonal 48 thermocycler according to exact thermal conditions for each PCR 
reaction. PCR products were electrophoresed into pre-stained agarose gel and were detected 
under ultraviolet transillumination. 
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Primers for Genus Mycoplasma PCR; 
Forward primer (GPF) 5’- GCT GGC TGT GTG CCT AAT ACA -3’ 
Reverse primer (MGSO) 5’- TGC ACC ATC TGT CAC TCT GTT AAC CTC -3’ 
Master Mix composition: 
Component Quantity (µl) 
10X Dream Taq Buffer 2.5 
dNTP Mix, 2 mM each 1.0 
Forward primer GPF (10 pmol/µl) 0.4 
Reverse primer MGSO (10 pmol/µl) 0.4 
Dream Taq DNA polymerase (5 Units/µl) 0.1 
Template DNA 2.5 
Water, nuclease-free 18.2 
Total volume 25 
Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 4 min 1 
Denaturation 94 30 sec  
35 Annealing 56 30 sec 
Extension 72 30 sec 
Final extension 72 10 min 1 
3.9. Polymerase chain reaction (PCR) for MG diagnosis and genotyping 
3.9.1. Mycoplasma gallisepticum (MG) species-specific PCR (Lierz et al., 2008b) 
Forward primer (MGF) 5’-CCA AGG CGA TGA CGT GTA GTT-3’ 
Reverse primer (MGR) 5’-CTG CAG CAC CGA AGT ATT CGC TC-3’ 
Master Mix composition: 
Component Quantity (µl) 
10X Dream Taq Buffer 2.5 
dNTP Mix, 2 mM each 1.0 
Forward primer MGF (10 pmol/µl) 0.4 
Reverse primer MGR (10 pmol/µl) 0.4 
Dream Taq DNA polymerase (5 Units/µl) 0.1 
Template DNA 2.5 
Water, nuclease-free 18.2 
Total volume 25 
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Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 4 min 1 
Denaturation 94 30 sec  
35 Annealing 60 30 sec 
Extension 72 30 sec 
Final extension 72 10 min 1 
 
3.9.2. Mycoplasma gallisepticum cytadhesin 2 (Mgc2) PCR (Garcia et al., 2005) 
Forward primer (Mgc2-F) 5’-CGC AAT TTG GTC CTA ATC CCC AAC A-3’ 
Reverse primer (Mgc2-R) 5’-TAA ACC CAC CTC CAG CTT TAT TTC C-3’ 
Master Mix composition: 
Component Quantity (µl) 
10X Dream Taq Buffer 2.5 
dNTP Mix, 2 mM each 1.0 
Forward primer Mgc2-F (10 pmol/µl) 1.0 
Reverse primer Mgc2-R (10 pmol/µl) 1.0 
Dream Taq DNA polymerase (5 Units/µl) 0.1 
Template DNA 2.5 
Water, nuclease-free 16.9 
Total volume 25 
Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 3 min 1 
Denaturation 94 30 sec  
35 Annealing 58 30 sec 
Extension 72 60 sec 
Final extension 72 10 min 1 
 
3.9.3. MG 16S–23S rRNA IGSR (MG IGSR) PCR (Raviv et al., 2007a) 
Forward primer (MG-IGSR-F) 5’-GTA GGG CCG GTG ATT GGA GTT A-3’ 
Reverse primer (MG-IGSR-R) 5’-CCC GTA GCA TTT CGC AGG TTT G-3’ 
      
 
30 
 
Master Mix composition: 
Component Quantity (µl) 
10X Dream Taq Buffer 2.5 
dNTP Mix, 2 mM each 1.0 
Forward primer MG-IGSR-F (10 pmol/µl) 1.0 
Reverse primer MG-IGSR-R (10 pmol/µl) 1.0 
Dream Taq DNA polymerase (5 Units/µl) 0.1 
Template DNA 2.5 
Water, nuclease-free 16.9 
Total volume 25 
Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 3 min 1 
Denaturation 94 20 sec  
30 Annealing 55 30 sec 
Extension 72 60 sec 
Final extension 72 10 min 1 
3.9.5. Semi-nested MG 16S-23S IGSR PCR  
We designed this semi-nested MG 16S-23S IGSR PCR through the present study to improve 
sensitivity of MG 16S-23S IGSR PCR. The new PCR design included two PCRs. Briefly, the first PCR 
targeted a longer segment of the MG 16S-23S IGSR due to inclusion of a new forward primer 
which is located upstream of the former forward primer, while the second PCR was the same 
used in the conventional MG 16S-23S IGSR PCR (Figure 1). 
3.9.5.1. MG 16S-23S IGSR PCR-1 
For this PCR, a genus-specific Mycoplasma primer (16S-F-MYC) located in the 16S rRNA gene 
(Volokhov et al., 2006) was utilized as a forward primer. The 16S-F-MYC primer was found to be 
located upstream of the forward primer of the MG 16S-23S IGSR PCR (Figure 1). The 16S-F-MYC 
primer was paired with the MG reverse primer (MG IGSR R) located in the 23S rRNA  (Raviv et 
al., 2007a) (Figure 1). This PCR included 20 cycles of denaturation, annealing and extension, in 
addition to initial denaturation and final extension. 
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Forward primer (16S-F-MYC) 5’- GGT GAA TAC GTT CTC GGG TCT TGT ACA CAC -3’    (Volokhov et 
al., 2006) 
Reverse primer (MG IGSR R) 5’-CCC GTA GCA TTT CGC AGG TTT G-3’    (Raviv et al., 2007a) 
Master Mix composition: 
Component Quantity (µl) 
10X Dream Taq Buffer 2.5 
dNTP Mix, 2 mM each 1.0 
Forward primer (16S-F-MYC) (10pmol/ul) 1.0 
Reverse primer (MG IGSR R) (10pmol/ul) 1.0 
Dream Taq DNA polymerase (5 Units/ul) 0.1 
Template DNA 2.5 
Water, nuclease-free 16.9 
Total volume 25 
 
Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 3 min 1 
Denaturation 94 20 sec  
20 Annealing 55 30 sec 
Extension 72 60 sec 
Final extension 72 10 min 1 
 
3.9.5.2. MG 16S-23S IGSR PCR-2  (Raviv et al., 2007a) 
Procedures of this PCR were done as above mentioned for the MG 16S–23S rRNA IGSR (MG 
IGSR) PCR (Raviv et al., 2007a). This PCR was done using MG specific primers (MG IGSR F and 
MG IGSR R) with inclusion of 1 µl amplification product of the first MG 16S-23S IGSR PCR as a 
template DNA (Figure 1). 
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Figure 1: Schematic diagram of semi-nested MG 16S-23S IGSR-PCR indicating primers and their 
start point (for Forward primers) and end point (for reverse primer) in MG-R-high-strain 
(NC_017502.1). For the first PCR, 16S-F-MYC and MG IGSR-R primers were used, while for the 
second PCR, MG IGSR-F and MG IGSR-R primers were used. 
 
3.9.6. MG phase-variable putative adhesin (pvpA) PCR (Liu et al., 2001) 
Forward primer (PvpA-F) 5’-GCC AMT CCA ACT CAA CAA GCT GA -3’ 
Reverse primer (PvpA-R) 5’-GGA CGT SGT CCT GGC TGG TTA GC-3’ 
Master Mix composition: 
Component Quantity (µl) 
10X HotStar Taq Buffer 2.5 
dNTP Mix, 2 mM each 2.5 
Forward primer PvpA-F (10pmol/µl) 1.0 
Reverse primer PvpA-R (10pmol/µl) 1.0 
HotStar Taq DNA polymerase (5 Units/µl) 0.10 
Template DNA 2.5 
Water, nuclease-free 15.35 
Total volume 25 
Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 15 min 1 
Denaturation 94 30 sec  
40 Annealing 55 30 sec 
Extension 72 60 sec 
Final extension 72 10 min 1 
3.9.7. Semi-nested MG PvpA-PCR (Liu et al., 2001) 
This semi-nested MG pvpA-PCR was used to improve sensitivity of the conventional MG pvpA-
PCR. The new PCR design included two PCRs. Briefly, the first PCR is the same like the 
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conventional MG pvpA-PCR , while the second PCR targeted a shorter segment of the MG pvpA 
due to inclusion of a new forward primer which is located downstream of forward primer 
(Figure 2).  
3.9.7.1. MG pvpA PCR-1 (Liu et al., 2001) 
For this PCR, PvpA-F and PvpA-R primers used in MG pvpA PCR were utilized (Figure 2). 
Procedures of the first MG pvpA PCR are the same as above mentioned in the MG putative 
cytadhesin protein A (PvpA) PCR (Liu et al., 2001) but for only 20 cycles (denaturation, annealing 
and extension). 
3.9.7.2. MG pvpA PCR-2 (Liu et al., 2001) 
For this PCR, a new primer (MG pvpA-F2) located downstream of forward primer (MG pvpA-F), 
was used as a forward primer. The new forward primer (MG pvpA-F2) was used together with 
the MG pvpA-R (Liu et al., 2001) (Figure 2). This PCR was used to improve sensitivity although it 
targeted a smaller genome segment than conventional MG pvpA PCR. The second MG pvpA PCR 
was performed by including 1 µl of first MG pvpA PCR as a template DNA (Figure 2). 
Forward primer (PvpA-F2) 5’-GGT AGT CCT AAG TTA TTA GGT C -3’ 
Reverse primer (PvpA-R) 5’-GGA CGT SGT CCT GGC TGG TTA GC-3’ 
 
Master Mix composition: 
Component Quantity (µl) 
10X Hotstar Taq Buffer 2.5 
dNTP Mix, 2 mM each 2.5 
Forward primer (PvpA-F2) (10pmol/ul) 0.5 
Reverse primer (PvpA-R) (10pmol/ul) 0.5 
Hotstar Taq DNA polymerase (5 Units/ul) 0.15 
Template DNA (from first PCR product) 1.0 
Water, nuclease-free 17.85 
Total volume 25 
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Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 15 min 1 
Denaturation 94 30 sec  
35 Annealing 55 30 sec 
Extension 72 60 sec 
Final extension 72 10 min 1 
 
 
Figure 2: Schematic diagram of semi-nested MG PvpA-PCR indicating primers and their start 
point (for Forward primers) and end point (for reverse primer) in MG-R-high-strain 
(NC_017502.1). For the first PCR, MG-PvpA-1F and MG-PvpA-2R primers were utilized, while for 
the second PCR, MG-PvpA-3F and MG-PvpA-2R primers were used (Modified from (Liu et al., 
2001)). 
 
3.10. Polymerase chain reaction (PCR) for MS diagnosis and genotyping 
3.10.1. Mycoplasma synoviae (MS) species-specific PCR (Marois et al., 2000) 
Forward primer (MSF) 5’-GAG AAG CAA AAT AGT GAT ATC A-3’ 
Reverse primer (MSR) 5’-CAG TCG TCT CCG AAG TTA ACA A-3’ 
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Master Mix composition: 
Component Quantity (µl) 
10X Dream Taq Buffer 2.5  
dNTP Mix, 2 mM each 1.0 
Forward primer MSF (10pmol/µl) 0.4 
Reverse primer MSR (10pmol/µl) 0.4 
Dream Taq DNA polymerase (5 Units/µl) 0.1 
Template DNA 2.5 
Water, nuclease-free 18.2 
Total volume 25 
 
Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 4 min 1 
Denaturation 94 30 sec  
35 Annealing 56 30 sec 
Extension 72 30 sec 
Final extension 72 10 min 1 
3.10.2. MS variable lipoprotein and haemagglutinin (vlhA) PCR (Jeffery et al., 2007) 
Forward primer (vlhA-F) 5’- TAC TAT TAG CAG CTA GTG C-3’ 
Reverse primer (vlhA-R) 5’- AGT AAC CGA TCC GCT TAA T-3’ 
Master Mix composition: 
Component Quantity (µl) 
10X Dream Taq Buffer 2.5 
dNTP Mix, 2 mM each 1.0 
Forward primer MS-cons-F (10pmol/µl) 0.4 
Reverse primer MS-cons-R (10pmol/µl) 0.4 
Dream Taq DNA polymerase (5 Units/µl) 0.1 
Template DNA 2.5 
Water, nuclease-free 18.1 
Total volume 25 
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Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 4 min 1 
Denaturation 94 30 sec  
35 Annealing 54 30 sec 
Extension 72 60 sec 
Final extension 72 10 min 1 
 
3.10.3. Revised MS variable lipoprotein and haemagglutinin (vlhA) PCR (Wetzel et al., 
2010) 
For this MS-vlhA-PCR, degenerating primers were used to improve sensitivity efficiency. 
Forward primer (Rev-vlhA-F) 5’- CCA TTG CTC CTG CTG TTA T -3’ 
Reverse primer (Rev-vlhA-R) 5’- KMT KCT GTT GTA GTT GCT TCA A -3’ 
Master Mix composition: 
Component Quantity 
10X Dream Taq Buffer 2.5 
dNTP Mix, 2 mM each 1.0 
Forward primer Rev-vlhA-F (10pmol/µl) 1.0 
Reverse primer Rev-vlhA-R (10pmol/µl) 1.0 
Dream Taq DNA polymerase (5 Units/µl) 0.15 
Template DNA 2.5 
Water, nuclease-free 16.85 
Total volume 25 
 
Thermal program: 
Step Temperature, °C Time Number of cycles 
Initial denaturation 94 4 min 1 
Denaturation 94 30 sec  
40 Annealing 55 30 sec 
Extension 72 60 sec 
Final extension 72 10 min 1 
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3.10.4. Nested MS vlhA-PCR  
This nested PCR was designed through the present study to improve sensitivity of conventional 
MS vlhA-PCR assays. Briefly, it was observed that MS-cons-F and MS-cons-R primers of Jeffery 
design (Jeffery et al., 2007) are located upstream of Rev-vlhA-F and Rev-vlhA-R primers of 
Wetzel design (Wetzel et al., 2010) in the conserved segment of the MS vlhA gene. The new 
nested MS vlhA-PCR design combined both Jeffery design and Wetzel design in a nested PCR 
design with minor modification (Figure 3).  
The first MS vlhA-PCR was conducted using MS-cons-F and MS-cons-R primers with thermal 
conditions as described (Jeffery et al., 2007). It included 20 cycles of denaturation, annealing 
and extension, in addition to initial denaturation and final extension.  
One µl of the first PCR product was used as template DNA in the second MS-vlhA-PCR. The 
second MS vlhA-PCR was done using vlhA-rev-F and vlhA-rev-R primers with thermal conditions 
as described (Wetzel et al., 2010).  
 
 
Figure 3: Schematic diagram of nested MS vlhA-PCR indicating primers and their start point (for 
Forward primers) and their end point (for reverse primer) in MS 53 strain (AE017245.1).  
 
3.11. Chemicals and devices for agarose gel electrophoresis 
Agarose NEEO ultra-Qualität Roth, Karlsruhe 
GeneRuler 100 bp DNA ladder and 
6X Loading Dye       
Thermo Scientific, Braunschweig 
 
GelRed stain (10,000 X) Biotium, Hayward, USA 
UV-transilluminator (Biometra TI 5)       Biometra, Göttingen 
Gel image Documentation system 
(BioDocAnalyze digital) 
Biometra, Göttingen 
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Tris-Borat-EDTA-Buffer (TBE)-Buffer (10X concentration) (1000 ml solution) 
108 g   Tris                                            Roth, Karlsruhe 
55   g     Boric acid                                Merck, Darmstadt 
40 ml 0,5 M EDTA (Roth) pH 8,0       Merck, Darmstadt 
PH is adjusted to 8,0 with 4 M NaOH and complete up to 1000 ml with distilled water. 
For agarose gel preparation and electrophoresis buffer, 1X TBE solution was used. 
3.12. Agarose gel electrophoresis 
A range of 1-2% agarose concentrations in 1X TBE was prepared according to the expected 
molecular weight of the PCR products. GelRed stain (at 1:10,000 working concentration) was 
added to agarose solution. The solution was heated to boiling in a microwave for 3 minutes and 
left to warm before pouring in Gel casting chamber. PCR products were mixed with 6X loading 
dye before loading onto solidified casted gel. DNA ladder or GeneRuler 100 bp DNA ladder were 
included to confirm the molecular weight of amplicons. Electrophoresis was carried out for 45 
minutes at 120 Voltage. Bands were detected under UV-transilluminator and photos were 
documented using BioDocAnalyze digital. 
3.13. Chemicals and devices for PCR product purification 
GeneJET PCR Purification Kit Thermo Scientific, Braunschweig 
GeneJET gel Purification Kit     Thermo Scientific, Braunschweig 
Thermo mixer Comfort Eppendorf, Hamburg 
UV-transilluminator (Biometra TI 5)       Biometra, Göttingen 
 Gel image Documentation system 
(BioDocAnalyze digital) 
Biometra, Göttingen 
 
3 M sodium acetate, pH 5.2 solution Roth, Karlsruhe 
 
3.14. PCR product purification 
PCR product was purified from PCR solution (in case of appearance of only specific band on 
agarose electrophoresis) or from agarose (in case of appearance of non-specific bands beside 
the specific band on agarose electrophoresis). 
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3.14.1. PCR product purification from PCR solution 
For PCR fluid purification, GeneJET PCR Purification Kit (Thermo Scientific, Braunschweig) was 
used according to manufacturer’s recommendations. Briefly, PCR fluid was adjusted to 100 µl 
with sterile PBS followed by thorough mixing. Hundred µl of Binding Buffer (yellow colour) were 
added followed by thorough mixing. In case the color of the solution is orange or violet, 10 µl of 
3 M sodium acetate solution were added to the mixture. The mixture was brought onto the 
GeneJET purification spin column.  
The spin column was centrifuged at 6000 g for 1 minute and the flow-through was discarded. 
The spin column was washed with 700 µl Wash Buffer and the flow-through was discarded. 
Empty spin columns were centrifuged for additional 1 minute for complete removal of wash 
buffer residues. Elution of purified DNA was done in 30 µl elution buffer. 
3.14.2. PCR product purification from agarose 
For PCR purification from agarose, GeneJET gel Purification Kit (Thermo Scientific, 
Braunschweig) was used according to the manufacturer’s recommendations. Specific bands 
were cut from agarose using a clean scalpel and put into a 2 ml eppendorf tube. Binding buffer 
was added to the excised band with 1:1 volume. The agarose mixture was melted by incubation 
at 50-60 °C for 10 minutes on a thermo mixer till homogenization. In case the color of the 
solution was orange or violet, 10 µl of 3 M sodium acetate solution were added to the mixture. 
The mixture was brought onto the GeneJET purification spin column. 
The following steps were the same as mentioned above for the PCR product purification from 
PCR fluid. 
 
3.15. Program used for sequence analysis and alignment 
Sequencing company LGC Genomics GmbH, Berlin 
Lasergene; DNASTAR, Inc. , Madison, USA (for 
sequencing editing, alignment and 
phylogenetic tree construction) 
GATC Biotech, Konstanz 
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3.16. PCR product sequencing, sequence analysis and processing of amplicons 
Sequencing of PCR products was performed at LGC Genomics GmbH, Berlin, Germany. Resulting 
sequences were blasted against GenBank data (http://www.ncbi.nlm.nih.gov/). Sequence 
editing, alignments and phylogenetic tree construction were done using Lasergene; DNASTAR, 
Inc., Madison, USA (GATC Biotech, Konstanz). Resulting sequences and respective sequences 
obtained from GenBank were edited to have the same start and end nucleotide sequence. 
Afterwards, sequences were aligned by the Clustal W method. Phylogenetic trees were 
constructed and the relationship between sequences was estimated by MegAlign program 
(Lasergene; DNASTAR, Inc., Madison, USA). 
3.17. Chemicals and devices for restriction fragment length polymorphism of MG 
putative cytadhesin (PvpA-RFLP) 
Digestion Buffer G (10X) Thermo Scientific, Braunschweig 
GeneRuler Low Range DNA ladder (from 25 
bp to 700 bp) 
Thermo Scientific, Braunschweig 
Water bath            Köttermann Labortechnik, Uetze-Hänigsen 
Restriction endonuclease enzymes for PvpA-RFLP 
Enzyme Recognition site Concentration Company 
PvuII 5'...C A G↓C T G...3' 
3'...G T C↑G A C...5' 
10 U/μl Thermo Scientific, 
Braunschweig 
XmiI (AccI)  5'...G T↓M K A C...3' 
3'...C A K M↑T G...5' 
10 U/μl Thermo Scientific, 
Braunschweig 
Bme (ScrFI) 5'...C C↓N G G...3' 
3'...G G N↑C C...5' 
10 U/μl Thermo Scientific, 
Braunschweig 
3.18. PvpA- restriction fragment length polymorphism (PvpA-RFLP) (Pillai et al., 2003) 
Procedures for pvpA-PCR were performed as mentioned above for the MG pvpA-PCR and as 
described (Liu et al., 2001). Afterwards, the pvpA-PCR product was digested by each of PvuII, 
AccI and ScrFI restriction enzymes separately. The digestion mixture contained 18 µl of the PCR 
product, 3 µl 10X Buffer G and 2 µl restriction enzyme. The digestion mixture was completed to 
30 µl total volume with distilled water. Digestion mixtures were incubated in water bath at 37°C 
for 8 hours and was then separated on 3% agarose gel pre-stained with GelRed (1:10,000 
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working concentration) for 3-4 hours at 85 Voltage. GeneRuler Low Range DNA ladder was 
included to confirm the molecular weight of amplicons. Bands were detected under UV-
transilluminator and documented using BioDocAnalyze digital. 
 
3.19. Chemicals and devices for amplified fragment length polymorphism (AFLP) 
DNA automatic sequencer (DNA-Analyzer 4200) LI-COR Inc., USA 
GenelmaglR Release 4.05 Scanalytics Inc., USA 
Endonuclease restriction enzymes Thermo Scientific, Braunschweig 
Digestion Buffer G (10X) Thermo Scientific, Braunschweig 
T4 DNA ligase enzyme                  Thermo Scientific, Braunschweig 
T4 ligase Buffer                           Thermo Scientific, Braunschweig 
DNA adapters and oligonucleotides primers  Biomers, Ulm 
       
Chemicals for denaturing polyacrylamide gel 
Acrylamide solution (LongRanger Gel solution) Biozym, Oldendorf 
Urea Roth, Karlsruhe 
APS (Ammonium persulphate) Roth, Karlsruhe 
Boric acid  Roth, Karlsruhe 
EDTA Roth, Karlsruhe 
TEMED Roth, Karlsruhe 
Formamid (deionized) Roth, Karlsruhe 
Fuchsin AppliChem, Darmstadt 
Restriction endonuclease enzymes used for AFLP 
Enzyme Recognition site Concentration Company 
BglII 5'...A↓G A T C T...3' 
3'...T C T A G↑A...5' 
10 U/μL Thermo Scientific, 
Braunschweig 
MunI (MfeI) 5'...C↓A A T T G...3' 
3'...G T T A A↑C...5' 
10 U/μL Thermo Scientific, 
Braunschweig 
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DNA adapters and primers sequences used for AFLP 
Oligonucleotide Sequence (5’---3’) Company 
BGL adapter CGG ACT AGA GTA CAC TGT Biomers, Ulm 
GAT CGA CAG TGT ACT CTA GTC Biomers, Ulm 
MFE adapter AAT TCC AAG AGC TCT CCA GTA Biomers, Ulm 
TAG TAC TGG AGA GCT CTT GG Biomers, Ulm 
Mfe1 (labeled with 
DY781) 
GAG AGC TCT TGG AAT TGA Biomers, Ulm 
Bgl2F (labeled with 
DY781) 
GAG TAC ACT GTC GAT CT Biomers, Ulm 
3.20. Amplified fragment length polymorphism (AFLP) (Hong et al., 2005b) 
Approximately 400 ng of MG or MS genomic DNA were double digested with 10 units of BglII 
and 10 units of MfeI enzymes in a total volume of 20 ul. The digestion mixture was incubated in 
a water path for 3 hours at 37°C. Two pmol of the BGL adaptor and 20 pmol of the MFE adaptor 
were ligated to 5 µl (100 ng) of digested DNA, in the presence of 10 U of T4 DNA ligase enzyme 
in a final volume of 20 µl ligation mixture. Ligation was done overnight at room temperature. 
Amplification of ligated-restricts was performed in a volume of 25 µl PCR reaction mix. PCR 
reaction mix included 5 µl of 10-fold diluted ligation mixture, 2.5 µl of 10X Dream Taq Buffer, 5 
µl dNTPS (2 mM each), 5 pmol of Bgl2F and Mfe1 primers and 1.5 units of Dream Taq DNA 
polymerase. The Thermal program consisted of initial denaturation at 94°C for 4 min, followed 
by 30 cycles of denaturation at 94°C for 60 sec, annealing at 54°C for 60 sec and extension at 
72°C for 90 sec, and a final extension at 72°C for 10 min. PCR product was 1:5 diluted with Licor 
Buffer (Formamide, EDTA and Fuchsin) followed by denaturation at 93°C for 3 min and quickly 
chilled on ice. The PCR product was separated on an 8% denaturing polyacrylamide gel. PCR 
fragments between 71 and 431 bp were detected on a DNA automatic sequencer (DNA-Analyzer 
4200, LI-COR Inc., USA). Fragment sizes and pattern variations were analyzed by GenelmaglR 
Release 4.05, (Scanalytics Inc., USA). Background subtraction, data normalization, and cluster 
analysis was performed using the Pearson correlation and un-weighted pair group methods with 
average linkages. 
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3.21. Index of discrimination (D) (Hunter and Gaston, 1988) 
The discriminatory power of each typing method has been compared through the discrimination 
(D) index (Hunter and Gaston, 1988). D-index refers to the ability of a typing method to 
distinguish between different strains and measures the probability that two unrelated strains 
will be placed into different groups. D-index is calculated using Simpson diversity or 
discrimination (D) index, which takes into account the number of types defined by the method 
and the relative frequencies of these types.  
A D index of > 0.90 is considered adequate, and a D-index > 0.95 is considered as a good typing 
method. This index can be calculated by the following equation; 
D 1  
1
N(N 1)
 ∑  n (n  1)
S
n 1
 
N is the total number of strains in the sample population, S is the total number of types 
described, and nj is the number of strains belonging to the jth type. 
 
3.22. Reference and vaccine strains 
 MG strains 
MG 6/85 strain (vaccine strain) (Mycovac-L, Intervet) 
MG F-strain (vaccine strain) (F Vax-MG, Schering-Plough Animal Health) 
 MS reference strain 
 MS WUV 1853 strain (reference strain) 
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4. Results 
The present study included two parts or stages. Through the first part of the study, MG and MS 
diagnostic and genotyping methods were investigated and compared. Through this part, birds 
with suspension of Mycoplasma infection were sampled. Collected samples were tested for 
Mycoplasma spp. by cultivation and Genus Mycoplasma PCR and positive samples for 
Mycoplasma spp. were further tested by MG/MS species-specific PCR and. Positive MG or MS 
samples were subjected to genotyping. The discriminatory powers of different genotyping 
methods were compared. 
Through the second part of present study, samples from naturally infected chicken and the 
contacting non-poultry birds were collected and examined for MG and MS infection. Genetic 
profiles of MG and MS from both hosts were compared by established genotyping method.      
4.1. MG and MS incidence and genotyping  
In this part of the study, 515 swabs (tracheal and choanal) from 104 poultry and backyard flocks 
were examined (Table 1). These cases represented suspected cases for Mycoplasma infection 
(cases with respiratory or locomotor disorders or fertility troubles). In this part of the study, 
swabs (tracheal, pharyngeal, choanal, lung, synovial and phallus) were collected from different 
flocks (Table 1).  
Some of investigated flocks originated from the same farm but from different occasions. This 
case was met with 3 farms; 
1- Turkey farm located in East Germany from which 8 MG isolates originating from 8 different 
flocks were received and included in the present study. The eight flocks were divided as 
following;  
i. Two historical turkey breeder flocks (identity No.: 1608-1/11/TK and 1608-2/11/TK) 
from 2006 and 2007 MG outbreaks, respectively.  
ii. Four turkey breeder flocks (identity no.: 1608- 3, 4, 5, 6/11/TK) from MG outbreaks in 
2011.  
iii. Two fattening turkey flocks (identity No.: 1608-7/11/TK and 1608-8/11/TK) from 2011 
MG outbreaks.  
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2- Turkey breeder farm in Thüringen, Germany, where 4 flocks (identity No.: 632/11/TK, 
2730/11/TK, 24/12/TK and 187/12/TK) were examined through 2011 and 2012.  
3- Organic chicken breeder farm located in Wiesbaden, Germany, from which 5 flocks (identity 
No.: 2122/12/CK, 833/13/CK, 1233/13/CK, 1372/13/CK and 331/14/CK) were examined 
through 2012, 2013 and 2014. 
4.1.1. MG and MS identification by PCR and culture 
Out of 104 examined flocks, 76 tested positive in a Mycoplasma genus-specific PCR. From these 
positive flocks, 26 and 37 tested positive for MG- and MS- species specific PCR, respectively 
(Table 2). These PCR results were confirmed by amplicon sequencing. Double MG/MS infection 
was revealed in thirteen of the positive flocks (Table 2). On the other hand, cultivation was 
successful only with samples from 8 flocks (for MG) and 6 flocks (for MS), respectively (Table 2). 
MG isolates originated from one turkey farm (1608/11/TK) located in East Germany but from 
different occasions and different years (Table 2). However 3 of the MS isolates (2730/11/TK, 
24/12/TK and 187/12/TK) originated from one turkey breeder farm but from 3 different MS 
outbreaks that appeared at the winter of 2011 and 2012.  Each of the other 3 MS isolates 
(2072/11/CK, 2081/11/CK and 2141/11/CK) originated from different farms (Table 2). 
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Table 2: List of samples that tested positive for MG and MS isolation and species-specific PCR  
  Entry number 
Sampling 
date 
MG 
Isolation 
MG 
PCR 
MS 
Isolation 
MS 
PCR 
Notes 
1 632/11/TK 04.2011 - - - + Turkey breeders in Thüringen 
2 1321/11/CK 06.2011 - + - - Chicken with resp. signs 
3 1608/1/11/TK 2006 + + - - Turkey breeders in East Germany 
4 1608/2/11/TK 2007 + + - - Turkey breeders in East Germany 
5 1608/3/11/TK 07.2011 + + - - Turkey breeders in East Germany 
6 1608/4/11/TK 07.2011 + + - - Turkey breeders in East Germany 
7 1608/5/11/TK 07.2011 + + - - Turkey breeders in East Germany 
8 1608/6/11/TK 07.2011 + + - - Turkey breeders in East Germany 
9 1608/7/11/TK 07.2011 + + - - Fattening turkey in East Germany – MG 6/85 strain vaccinated 
10 1608/8/11/TK 07.2011 + + - - Fattening turkey  in East Germany – MG 6/85 strain vaccinated 
11 2038/11/CK 08.2011 - + - - NA 
12 2072/11/CK 09.2011 - - + + Chicken with resp. signs 
13 2081/11/CK 09.2011 - + + + Chicken with resp. Signs 
14 2141/11/TK 10.2011 - - + + NA 
15 2730/11/TK 12.2011 - - + + Turkey breeders in Thüringen 
16 24/2012/TK 01.2012 - - + + Turkey breeders in Thüringen 
17 187/12/TK 01.2012 - - + + Turkey breeders in Thüringen 
18 1567/12/CK 07.2012 - - - + Chicken with resp. Signs 
19 1786/12/CK 08.2012 - + - + Chicken with resp. Signs 
20 1858/12/CK 09.2012 - + - + Chicken with resp. Signs Chicken 
21 1907/12/CK 09.2012 - + - + NA 
22 1936/12/CK 09.2012 - + - + NA 
23 2122/12/CK 10.2012 - + - + Organic Chicken breeders in Wiesbaden, with infertility problems  
24 2187/12/CK 10.2012 - + - - NA 
25 2207/12/CK 10.2012 - - - + Chicken with resp. Signs & infertility problems 
26 2286/12/CK 10.2012 - - - + Chicken with resp. Signs 
27 2453/12/CK 11.2012 - + - + Chicken with resp. Signs 
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 Entry number 
Sampling 
date 
MG 
Isolation 
MG 
PCR 
MS 
Isolation 
MS 
PCR 
Notes 
28 19/13/CK 01.2013 - - - + NA 
29 154/13/CK 01.2013 - - - + NA 
30 209/13/CK 01.2013 - - - + NA 
31 342/13/CK 02.2013 - - - + NA 
32 364/13/CK 03.2013 - + - + Chicken with resp. Signs 
33 370/13/CK 02.2013 - - - + Chicken with resp. Signs 
34 612/13/CK 03.2013 - + - + Chicken with resp. Signs 
35 833/13/CK 04.2013 - - - + Organic Chicken breeders in Wiesbaden, with infertility problems  
36 925/13/CK 04.2013 - + - + NA 
37 1233/13/CK 06.2013 - - - + Organic Chicken breeders in Wiesbaden, with infertility problems  
38 1372/13/CK 06.2013 - - - + Organic Chicken breeders in Wiesbaden, with infertility problems  
39 1554/13/CK 07.2013 - - - + NA 
40 1561/13/CK 07.2013 - + - + Chicken with swollen sinuses & resp. & infertility problems 
41 1847/13/CK 08.2013 - + - - NA 
42 1911/13/CK 08.2013 - - - + NA 
43 2054/13/CK 09.2013 - - - + NA 
44 2087/13/CK 09.2013 - - - + Organic chicken with resp. Signs 
45 2251/13/CK 09.2013 - - - + Chicken with resp. Signs & eggshell misshape 
46 2591/13/CK 11.2013 - + - - NA 
47 77/14/CK 02.2014 - + - + Organic layer chicken with resp. Signs 
48 331/14/CK 02.2014 - + - + Organic Chicken breeders in Wiesbaden, with infertility problems  
49 600/14/CK 03.2014 - - - + Chicken with resp. Signs 
50 1073/14/CK 07.2014 - - - + NA 
This table showing 26 MG samples by species-specific PCR and 8 from them is positive with MG cultivation. Also 37 samples were 
positive with MS species-specific PCR and 6 from them had cultivable MS. A total of 13 samples are positive for MG/MS co-infection. 
Sample description: entry number/year of sampling/bird species.  
For bird species: CK = chicken; GS= Goose; PH=Pheasants; SW= Swan; Tit= Blue and grey tits; TK = turkey and ZF=Zebra finches 
*samples 1608-1/11/TK and 1608-2/11/TK were isolated in 2006 and 2007, respectively, but were investigated during this work. 
 (+) =positive, (-) = negative and (NA) = Not available.
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4.1.2. MG typing by mgc2 sequencing 
PCR and sequencing of mgc2 differentiated 3 different sequence types within MG positive 
samples (n = 26) that belonged to two main clusters. The first cluster included 8 samples that 
produced an approximately 230 bp amplicon. Six samples from them belonged to one sequence 
type (M-I) (identical to mgc2 of MG 6/85 vaccine strain), while the other two samples belonged 
to another sequence type (M-II). Cluster II contained 18 samples that showed amplicons of 
approximately 300 bp and belonged to sequence type M-III, identical to mgc2 of MG ts-11 
vaccine strain (Figure 4). Concerning the turkey MG isolates, mgc2 sequence alignment 
differentiated 8 turkey MG isolates (1608-11/TK) into two sequence types (M-I and M-III); the 
two fattening turkey isolates from 2011 belonged to sequence type M-I (identical to MG 6/85 
vaccine strain) and the other 6 breeder isolates from 2006, 2007 and 2011 belonged to 
sequence type M-III (Table 3). The D-index of mgc2 sequencing was 0.52.  
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Figure 4: Phylogenetic tree of the mgc2 sequences of MG samples and reference strains. 
Sequences of MG samples and compared MG reference strains were trimmed and edited to 
have the same starting and ending sequences. MG samples demonstrated 3 different mgc2 
sequence types. The turkey MG isolates (identity no. 1608-11/TK and shown in bold font) 
demonstrated two mgc2 sequence types. Phylogenetic tree produced with the use of Clustal-W 
alignment of MegAlign program (DNASTAR Lasergene, Madison, WI). 
Sample description: entry number-year of sampling-bird species (CK = chicken and TK = turkey)-
genome segment  
MG reference strain description: MG-Reference strain Identity-Accession number-genome 
segment  
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4.1.3. MG typing by MG 16S-23S IGSR sequencing 
With MG-IGSR PCR, amplicons of approximately 800 bp were produced with MG samples (n=26) 
with no visible size differences between samples on agarose electrophoresis. A range of 1 to 6 
nucleotides differences between samples was shown by MG-IGSR sequence alignment. MG-
IGSR sequence alignment differentiated 10 sequence types (from I-I to I-X) that fell into 4 main 
clusters; I, II, III and IV within samples (Figure 5 and Table 3). Cluster I included 6 samples that 
were closely related to the 6/85 vaccine strain. Cluster II and cluster III included 9 samples each, 
with no clear relationship to known reference strains. Samples 2038-11-CK and 925-13-CK 
composed cluster IV. Concerning the turkey MG isolates, MG-IGSR sequence alignment 
differentiated them into three sequence types (I-A3, I-B4 and I-C1); fattening turkey isolates 
from 2011 belonged to sequence type I-A3 (identical to MG 6/85 vaccine strain), breeder 
isolates from 2006 and 2011 seemed identical and belonged to sequence type I-C1, and breeder 
isolate from 2007 demonstrated different MG-IGSR sequence type I-B4 (Table 3). MG-IGSR 
sequencing showed a D-index of 0.86. 
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Figure 5: Phylogenetic tree of MG 16S-23S IGSR sequences for MG samples and MG reference 
strains. Sequences of MG samples and compared MG reference strains were trimmed and 
edited to have the same starting and ending sequences. MG samples demonstrated 10 16S-23S 
IGSR sequence types. Turkey MG isolates (shown in bold font) belonged to three different 16S-
23S IGSR sequence types. Phylogenetic tree produced with the use of Clustal-W alignment of 
MegAlign program (DNASTAR Lasergene, Madison, WI).  
Sample description: entry number-year of sampling-bird species (CK = chicken and TK = turkey)-
genome segment  
MG reference strain description: MG-Reference strain Identity-Accession number-genome 
segment 
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4.1.4. MG typing by pvpA sequencing 
With pvpA-PCR, MG samples showed PCR amplicons with three different molecular weights; 
approximately 600 (14 samples), 660 (10 samples) and 770 bp (1 sample). Sample 2187/12/CK 
was not tested by pvpA-PCR due to shortage of DNA. In total, pvpA sequencing differentiated 14 
pvpA sequence types that belonged to 6 clusters within samples (Figure 6). Cluster I included 5 
samples from which four samples showed a pvpA sequence identical to that of 6/85 vaccine 
strain. Cluster II included also 5 samples (4 MG turkey breeder isolates from 2011 together with 
historical MG turkey breeder isolates from 2006) that showed relationship to pvpA of MG ts-11 
vaccine and MG-R reference strains. Cluster III and IV included 5 samples each. Cluster V 
included turkey breeder MG isolate from 2007 and chicken MG isolate 1321-11/CK. Clusters VI 
included 3 MG isolates with no clear relationship to known MG reference strain (Figure 6). PvpA 
sequences of all samples showed two copies of direct repeats (DR), while chicken sample 
1561/13/CK demonstrated three DRs with approximately 770 bp pvpA-PCR product (Table 3). D-
index of pvpA sequencing of 0.94 was shown (Table 3). 
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Figure 6: Phylogenetic tree for pvpA sequences of MG samples and MG reference strains. 
Sequences of MG samples and compared MG reference strains were trimmed and edited to 
have the same starting and ending sequences. Samples demonstrating 14 pvpA sequence types. 
Eight turkey MG isolates (shown in bold font) showed three different sequence types. 
Phylogenetic tree produced with the use of Clustal-W alignment of MegAlign program 
(DNASTAR Lasergene, Madison, WI). 
      
 
54 
 
4.1.5. Multiple gene-targeted sequencing (GTS) of mgc2/pvpA/MG-IGSR sequencing 
Collective analysis of mgc2/pvpA/MG-IGSR sequencing discriminated 18 sequence types (from I 
to XVIII) over all samples (Table 3).  Multiple GTS analysis of mgc2/pvpA/MG-IGSR differentiated 
turkey MG isolates into 3 sequence types (I, II and IV); 4 breeder isolates from 2011 and one 
breeder isolate from 2006 were identical and belonged to GTS type I. Fattening turkey isolates 
belonged to GTS type II and were 100% identical to that of MG 6/86 vaccine strain. Breeder 
isolate from 2007 was different and demonstrated GTS type IV (Table 3). The D-index of 
multiple GTS was 0.95.  
Table 3: MG typing results by sequencing of the mgc2, pvpA and MG-IGSR, multiple GTS 
 
MG strain mgc2 bp 
mgc2 
seq. 
16-23 
IGSR 
(bp) 
16-23 
IGSR 
seq. 
pvpA 
(bp) 
pvpA 
seq. 
Multiple GTS 
(mgc2/ 
IGSR/pvpA) 
1 1321/11/CK A (~ 300 bp) M-I 813 I-B1 600 P-E III 
2 
1608-
1/11/TK* 
A (~ 300 bp) M-I 813 I-C1 660 P-D I 
3 
1608-
2/11/TK* 
A (~ 300 bp) M-I 813 I-B4 600 P-F IV 
4 1608-3/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D I 
5 1608-4/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D I 
6 1608-5/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D I 
7 1608-6/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D I 
8 1786/12/CK A (~ 300 bp) M-I 813 I-C1 600 P-C2 V 
9 1858/12/CK A (~ 300 bp) M-I 814 I-B2 660 P-A2 I 
10 1907/12/CK A (~ 300 bp) M-I 813 I-B1 600 P-G VI 
11 2122/12/CK A (~ 300 bp) M-I 813 I-B1 600 P-C3 VII 
12 2187/12/CK A (~ 300 bp) M-I 813 I-B3 - - XVIII 
13 2453/12/CK A (~ 300 bp) M-I 813 I-C1 600 P-C1 VIII 
14 925/13/CK A (~ 300 bp) M-I 809 I-E 660 P-A1 IX 
15 1561/13/CK A (~ 300 bp) M-I 813 I-B4 770 P-I X 
16 1847/13/CK A (~ 300 bp) M-I 813 I-C1 660 P-A1 XI 
17 2591/13/CK A (~ 300 bp) M-I 813 I-B1 660 P-A1 XII 
18 331/14/CK A (~ 300 bp) M-I 813 I-B1 600 P-C1 XIII 
19 1608-7/11/TK B (~ 230 bp) M-II 815 I-A3 600 P-B1 II 
20 1608-8/11/TK B (~ 230 bp) M-II 815 I-A3 600 P-B1 II 
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21 364/13/CK B (~ 230 bp) M-II 813 I-C2 600 P-H XIV 
22 612/13/CK B (~ 230 bp) M-II 815 I-A3 600 P-B1 II 
23 1936/12/CK B (~ 230 bp) M-II 815 I-A1 600 P-B2 XV 
24 77/14/CK B (~ 230 bp) M-II 815 I-A3 600 P-B1 II 
25 2038/11/CK B (~ 230 bp) M-III 814 I-D 660 P-A1 XVI 
26 2081/11/CK B (~ 230 bp) M-III 815 I-A2 600 P-C1 XVII 
Descriptive codes: Identity number /year/species). CK = chicken; TK = turkey; seq. = sequencing; 
~ = approximately 
*samples 1608-1/11/TK and 1608-2/11/TK were isolated in 2006 and 2007, respectively, but 
were investigated during present study. 
4.1.6. Accession numbers for MG isolates  
Resulting sequences of MG-IGSR and pvpA of this study were submitted to GenBank under 
accession numbers KP710059 to KP710084 (for MG-IGSR) and KP881244 to KP881268 (for 
pvpA). 
 
4.1.7. Global comparison of German MG 
Sequences of mgc2, pvpA and MG IGSR from MG strains found in other countries were 
downloaded from GenBank. Sequences were edited to have the same start and end nucleotide 
sequences and were then aligned with respective sequences of the present study. With the 
global comparison of mgc2, pvpA and MG-IGSR sequences, German MG strains seemed to form 
a separate cluster with particular genetic profile. Some MG isolates from other geographic 
localities were genetically similar in one or more genome segments. With comparison of mgc2 
gene sequences, some Russian and Italian MG strains showed relationship to German strains 
(Figure 7). With MG-IGSR sequences, German MG strains demonstrated characteristic profile 
and only some Russian MG strains showed similarity with German 6/85 like strain cluster (Figure 
8). Through pvpA gene comparison, speciality of German MG strains as well as the relationship 
between some Russian and German isolates in 6/85 like cluster were shown (Figure 9).  
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Figure 7: Phylogenetic tree for mgc2 sequences of MG samples, MG reference strains and MG 
strains in USA, Russia, Egypt and Italy. Sequences were trimmed and edited to have the same 
starting and ending sequences. Some Russian MG strains (shown in bold font) shared 
relationship to German MG. Phylogenetic tree produced with the use of Clustal-W alignment of 
MegAlign program (DNASTAR Lasergene, Madison, WI). 
Sample description: entry number-year of sampling-bird species (CK = chicken and TK = turkey)-
genome segment  
MG reference strain description: MG-Reference strain Identity-Accession number-genome 
segment 
Description of MG strains from other countries: Accession number-Country-genome segment 
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Figure 8: Phylogenetic tree of 16S-23S IGSR sequences for MG samples and MG strains found in 
USA, Russia, China, Egypt and Spain, together with reference strains. Sequences were trimmed 
and edited to have the same starting and ending sequences. Some Russian MG strains (shown in 
bold font) shared relationship to German MGs of the 6/85 strain cluster. Phylogenetic tree 
produced with the use of Clustal-W alignment of MegAlign program (DNASTAR Lasergene, 
Madison, WI). 
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Figure 9: Phylogenetic tree of pvpA sequences for MG samples and MG strains found in USA, 
Russia, China and Iran, together with MG reference strains. Sequences were trimmed and 
edited to have the same starting and ending sequences. Some Russian MG strains (shown in 
bold font) shared relationship to German MGs of the 6/85 strain cluster. Iranian MG strain fell 
into the German cluster with relationship to MG PG31 strain. Phylogenetic tree produced with 
the use of Clustal-W alignment of MegAlign program (DNASTAR Lasergene, Madison, WI). 
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4.1.8. MG typing by pvpA-RFLP 
Twenty-five samples were examined by pvpA-PCR. Chicken sample 2187/12/CK was excluded 
due to shortage of DNA. MG samples showed pvpA amplicons of three sizes, approximately 600 
bp (14 samples), 660 bp (10 samples) and 770 bp (1 sample). However, pvpA-RFLP differentiated 
6 RFLP groups within samples (from I to VI) (Table 4). The D-index of pvpA-RFLP was 0.81.  
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Table 4: Results of pvpA-RFLP genotyping for MG samples by using PvuII, AccI, and ScrFI restriction endonuclease enzymes 
 MG strain 
PCR 
product 
length (bp) 
PvuII fragments (bp) 
PvuII-
RFLP-
group 
AccI 
fragments 
(bp) 
AccI-
RFLP-
group 
ScrFI fragments 
(bp) 
ScrFI-
RFLP-
group 
RFLP-
group 
1 1608-1/11/TK  660 380+230+50  A 340+320 A 240+240+180  A I 
2 1608-3/11/TK  660 380+230+50  A 340+320 A 240+230+180 A I 
3 1608-4/11/TK 660 380+230+50  A 340+320 A 240+230+180 A I 
4 1608-5/11/TK 660 380+230+50  A 340+320  A 240+240+180  A I 
5 1608-6/11/TK 660 380+230+50  A 340+320 A 240+240+180  A I 
6 1608-7/11/TK 600 380+120+50+50 B Not cut B 360+240 B II 
7 1608-8/11/TK 600 380+120+50+50 B Not cut B 360+240 B II 
8 2081/11/CK 600 380+120+50+50 B Not cut B 360+240 B II 
9 1786/12/CK 600 380+120+50+50 B Not cut B 360+240 B II 
10 1907/12/CK 600 380+120+50+50 B Not cut B 360+240 B II 
11 1936/12/CK 600 380+120+50+50 B Not cut B 360+240 B II 
12 2122/12/CK 600 380+120+50+50 B Not cut B 360-240 B II 
13 2453/12/CK 600 380+120+50+50 B Not cut B 360+240 B II 
14 364/13/CK 600 380+120+50+50 B Not cut B 360+240 B II 
15 612/13/CK 600 380+120+50+50 B Not cut B 360+240 B II 
16 77/14/CK 600 380+120+50+50 B Not cut B 360+240 B II 
17 331/14/CK 600 380+120+50+50 B Not cut B 360+240 B II 
18 2038/11/CK 660 Not cut  D Not cut C 275+240+145  D III 
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19 1858/12/CK 660 Not cut D Not cut C 275+240+145  D III 
20 925/13/CK 660 Not cut D Not cut C 275+240+145  D III 
21 1847/13/CK 660 Not cut D Not cut C 275+240+145  D III 
22 2591/13/CK 660 Not cut D Not cut C 275+240+145  D III 
23 1608-2/11/TK 600 380+170+50  C Not cut B 375+225  C IV 
24 1321/11/CK 600 380+120+50+50  B Not cut B 240+225+135 E V 
25 1561/13/CK 770 380, 120, 120, 50, 50, 50 E Not cut D 530+230 F VI 
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4.1.9. MG typing by Amplified Fragment Length Polymorphism (AFLP) 
AFLP applied to turkey MG isolates (n = 8) revealed 4 AFLP electrophoretic profiles (Figure 10 
and Table 5). Breeder isolate from 2006 showed electrophoretic profile (profile A1) that was 
similar (but not identical) to that of 4 breeder isolates from 2011 (profile A2). The two fattening 
turkey isolates were identical and showed electrophoretic profile (profile B) that was similar 
(but not identical) to the 6/85 vaccine strain. Unique AFLP profile was demonstrated with 
breeder isolate from 2007 (profile C) (Figure 10 and Table 5).  
 
 
Figure 10: AFLP analysis of 8 turkey MG isolates, MG 6/85 strain and MG F strain. Four turkey 
breeder isolates from 2011 (1608-3, 4, 5 and 6/11/TK) have identical patterns. They are similar 
(but not identical) to breeder MG isolate from 2006 (1608-1/11/TK). The two fattening turkey 
isolates (1608-7 and 8/11/TK) have identical patterns and they are similar to MG 6/85 strain. 
Turkey breeder MG isolate from 2007 (1608-2/11/TK) showed unique AFLP profile. Clustering of 
samples (dendrogram) was performed through LI-COR e-seq Release 2,0 program (LI-COR Inc, 
Lincolin, USA) using the un-weighted pair-group method with arithmetic averaging. 
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Table 5: MG typing results of sequencing the mgc2, pvpA and MG-IGSR, multiple GTS and the pvpA-RFLP and the AFLP 
 
MG strain mgc2 bp 
mgc2 
seq. 
16-23 
IGSR 
(bp) 
16-23 
IGSR seq. 
pvpA 
(bp) 
pvpA 
seq. 
pvpA-
RFLP 
Multiple 
GTS (mgc2/ 
IGSR/pvpA) 
AFLP 
1 1321/11/CK A (~ 300 bp) M-I 813 I-B1 600 P-E R-V III 
 
2 
1608-
1/11/TK* 
A (~ 300 bp) M-I 813 I-C1 660 P-D R-I I A-1 
3 
1608-
2/11/TK* 
A (~ 300 bp) M-I 813 I-B4 600 P-F R-IV IV C 
4 1608-3/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D R-I I A-2 
5 1608-4/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D R-I I A-2 
6 1608-5/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D R-I I A-2 
7 1608-6/11/TK A (~ 300 bp) M-I 813 I-C1 660 P-D R-I I A-2 
8 1786/12/CK A (~ 300 bp) M-I 813 I-C1 600 P-C2 R-II V 
 
9 1858/12/CK A (~ 300 bp) M-I 814 I-B2 660 P-A2 R-III I 
 
10 1907/12/CK A (~ 300 bp) M-I 813 I-B1 600 P-G R-II VI 
 
11 2122/12/CK A (~ 300 bp) M-I 813 I-B1 600 P-C3 R-II VII 
 
12 2187/12/CK A (~ 300 bp) M-I 813 I-B3 - - - XVIII 
 
13 2453/12/CK A (~ 300 bp) M-I 813 I-C1 600 P-C1 R-II VIII 
 
14 925/13/CK A (~ 300 bp) M-I 809 I-E 660 P-A1 R-III IX 
 
15 1561/13/CK A (~ 300 bp) M-I 813 I-B4 770 P-I R-VI X 
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16 1847/13/CK A (~ 300 bp) M-I 813 I-C1 660 P-A1 R-III XI 
 
17 2591/13/CK A (~ 300 bp) M-I 813 I-B1 660 P-A1 R-III XII 
 
18 331/14/CK A (~ 300 bp) M-I 813 I-B1 600 P-C1 R-II XIII 
 
19 1608-7/11/TK B (~ 230 bp) M-II 815 I-A3 600 P-B1 R-II II B 
20 1608-8/11/TK B (~ 230 bp) M-II 815 I-A3 600 P-B1 R-II II B 
21 364/13/CK B (~ 230 bp) M-II 813 I-C2 600 P-H R-II XIV 
 
22 612/13/CK B (~ 230 bp) M-II 815 I-A3 600 P-B1 R-II II 
 
23 1936/12/CK B (~ 230 bp) M-II 815 I-A1 600 P-B2 R-II XV 
 
24 77/14/CK B (~ 230 bp) M-II 815 I-A3 600 P-B1 R-II II 
 
25 2038/11/CK B (~ 230 bp) M-III 814 I-D 660 P-A1 R-III XVI 
 
26 2081/11/CK B (~ 230 bp) M-III 815 I-A2 600 P-C1 R-II XVII 
  
This table shows collective results of multiple GTS analysis, pvpA-RFLP and AFLP within MG samples. Multiple GTS analysis of 
mgc2/pvpA/MG-IGSR differentiated 18 sequence types (from I to XVIII). PvpA-RFLP differentiated 6 genotypes (from R-I to R-VI). 
AFLP could differentiate 4 genotypes within MG isolates. 
Sample description: entry number/year of sampling/bird species.  
For bird species: CK = chicken; GS= Goose; PH=Pheasants; SW= Swan; Tit= Blue and grey tits; TK = turkey and ZF=Zebra finches 
*samples 1608-1/11/TK and 1608-2/11/TK were isolated in 2006 and 2007, respectively, but were investigated during this work. 
seq. = sequencing; ~ = approximately 
*samples 1608-1/11/TK and 1608-2/11/TK were isolated in 2006 and 2007, respectively, but were investigated during present study. 
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4.1.10. MS typing by vlhA sequencing 
The vlhA gene of 36 MS samples was amplified and sequenced. Sample 154/13/CK was excluded 
because of DNA shortage. VlhA sequencing discriminated 15 vlhA sequence types. Two vlhA 
sequence types (I and II) predominated and included 22 samples (Figure 11). VlhA sequence 
type I included 12 MS samples. From those samples; three MS isolates (2730/11/TK, 24/12/TK 
and 187/12/TK) that originated from a turkey breeder farm in Thüringen, while the fourth 
isolate (632-11/TK) from an earlier MS outbreak in the same farm showed different vlhA 
sequence types (Figure 11). VlhA sequence type II included 10 MS samples in total. Four from 
these MS samples (833/13/CK, 1233/13/CK, 1372/13/CK and 331/14/CK) belonged to organic 
chicken farm located in Wiesbaden; however the fifth sample (2122-12/CK) from the same farm 
but from MS outbreak in 2012 showed different vlhA sequence type. All samples showed one 
vlhA amplicon, while sample 1561/13/CK showed two vlhA amplicons with two vlhA sequence 
types (1561-L-13-CK and 1561-S-13-CK) (Figure 11). The D-index of vlhA sequencing was 0.83.  
4.1.11. Global comparison of German MS 
With global comparison of MS-vlhA, German MS isolates seemed to have their particular genetic 
profile. The two German predominating MS strains (vlhA sequence types I & II) and Dutch MS 
strains showed identical vlhA gene sequences.. Also, some German MS strains showed similar 
vlhA with Japanese and Iranian MS strains (Figure 12).  
4.1.12. Accession numbers for MS isolates  
Resulting vlhA sequences of this part of study have been submitted to GenBank under accession 
numbers KP893761 to KP893801. 
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Figure 11: Phylogenetic tree for vlhA sequences of MS samples and MS reference strains. 
Sequences were trimmed and edited to have the same starting and ending sequences. MS 
samples demonstrated 15 vlhA sequence types. Two vlhA sequence types were more frequent 
than other types and were found in 22 MS samples. Phylogenetic tree produced with the use of 
Clustal-W alignment of MegAlign program (DNASTAR Lasergene, Madison, WI). 
Sample description: entry number-year of sampling-bird species (CK = chicken and TK = turkey)-
genome segment  
MS reference strain description: MS-Reference strain Identity-genome segment (vlhA)  
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Figure 12: Phylogenetic tree of vlhA sequences of MS samples and MS found in USA, Dutch, 
Japan, Italy and Iran, together with MS reference strains. Sequences were trimmed and edited 
to have the same starting and ending sequences. Some Dutch MS strains (shown in bold font) 
shared identical vlhA sequence with the two main German MS strains. Identical Phylogenetic 
tree produced with the use of Clustal-W alignment of MegAlign program (DNASTAR Lasergene, 
Madison, WI). 
Sample description: entry number-year of sampling-bird species (CK = chicken and TK = turkey)-
genome segment  
MS reference strain description: MS-Reference strain Identity-Accession number-genome 
segment 
Description of MS strains from other countries: Accession number-Country-genome segment 
(vlhA)  
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4.1.13. MS typing by Amplified Fragment Length Polymorphism (AFLP) 
MS isolates (n = 6) were differentiated into 3 electrophoretic profiles by AFLP. MS isolates 
(2730/11/TK, 24/12/TK and 187/12/TK) originating from turkey farm in Thüringen showed 
nearly identical AFLP profile. Turkey MS isolate 2141/11/TK and chicken MS isolate 2072/11/CK 
were genetically related and compromised another AFLP profile. The third AFLP profile was 
produced with chicken MS isolate 2081/11/CK (Figure 13). 
 
 
Figure 13: AFLP analysis of 6 MS isolates and MS WVU 1853 reference strain. Turkey breeder MS 
isolates 2730/11/TK, 24/12/TK and 187/12/TK originating from one turkey breeder farm are 
showed identical AFLP profile. Turkey MS isolate 2141/11/TK and chicken MS isolate 
2072/11/CK are similar. Chicken MS isolate 2081/11/CK are showing a third AFLP profile. 
Clustering of samples (dendrogram) was performed through LI-COR e-seq Release 2,0 program 
(LI-COR Inc, Lincolin, USA) using the un-weighted pair-group method with arithmetic averaging. 
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4.2.  MG and MS in poultry and free-ranging birds 
Through our investigation on MG and MS in poultry farms in the first part of the study, two 
organic chicken farms tested positive with MG/MS species-specific PCR. Large numbers of free-
ranging birds, especially house sparrows (Passer domesticus), were observed to come and share 
drinkers and feeders with reared birds during the daily open-air free rearing periods. The two 
farms were selected to study the role of free-ranging birds in MG/MS transmission under 
complete natural conditions. In farm I (Identity No.: 77/2014), Lohmann brown layers with mild 
respiratory manifestations, production problems and egg deformities, were reared. In farm II 
(Identity No.: 331/2014), Lohmann brown layer breeders suffering from fertility and hatchability 
problems, were kept. Farms were about 25 km from each other. 
. Samples from chicken and contacting free-ranging birds were simultaneously collected over 3 
days. Samples were investigated for MG and MS by culturing and species-specific PCR. MG 
strains were compared and typed through multiple GTS analysis of mgc2 gene, pvpA gene and 
the MG 16S-23S IGSR; the vlhA gene was sequenced and compared for MS typing.  
Samples of free-ranging birds tested negative with conventional MG IGSR-PCR, pvpA-PCR and 
vlhA-PCR. Semi-nested MG IGSR-PCR, semi-nested pvpA-PCR and nested vlhA-PCR were 
designed through the present study to improve sensitivity of respective PCRs. 
 
4.2.1. MG and MS detection in free-ranging birds 
From the area of farm I, 28 out of 74 samples (38%) from free-ranging birds tested positive for 
the Mycoplasma genus-specific PCR. Out of these Mycoplasma positive samples, 11 (15%) and 4 
(5.4%) tested positive with MG- and MS- specific PCR, respectively. In farm II, 13 out of 44 
samples (30%) from free-ranging birds were tested positive for Mycoplasma genus-specific PCR. 
From these positive samples, 5 tested positive for MG- (11%) and MS- (11%) species specific 
PCR, respectively. In total, from both farms’ areas (n=118 free-ranging birds’ samples), nucleic 
acids of genus Mycoplasma, MG and MS were detected in 41(35%), 16 (14%) and 9 (8%) birds, 
respectively. None of samples from free-ranging birds showed Mycoplasma growth on culture. 
However, chicken samples showed Mycoplasma colonies but, none of the colonies tested 
positive for MG or MS. 
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4.2.2. Sensitivity of newly designed PCRs 
Samples from free-ranging birds tested positive with MG species-specific PCR while they were 
negative with the conventional MG IGSR PCR and MG pvpA-PCR. Also samples from free-ranging 
birds tested positive with MS species-specific PCR while they were negative with both 
conventional MS vlhA-PCRs (Jeffery et al., 2007; Wetzel et al., 2010). So  we designed and used 
the semi-nested MG-16S-23S IGSR, semi-nested pvpA  and nested vlhA-PCR assays to overcome 
this problem with free-ranging birds investigated through the second part of the study. 
Newly designed semi-nested MG-16S-23S IGSR, semi-nested pvpA  and nested vlhA-PCR assays 
showed better sensitivity than respective conventional PCR assays. Two samples from free-
ranging birds from each farm tested positive with semi-nested MG-16S-23S IGSR PCR, however 
they were negative with conventional MG-16S-23S IGSR PCR. This was also true for the semi-
nested pvpA PCR, where 4 and 3 additional samples from free-ranging birds from farm I and 
farm II, respectively, tested positive. For the nested vlhA PCR, 4 and 5 additional samples from 
farm I and farm II, respectively, tested positive, while they were negative with both 
conventional MS-vlhA-PCR assays. 
 
4.2.3. MG typing by mgc2 sequencing 
Free-ranging birds from farm I and II as well as chickens from farm I produced amplicons of 
approximately 230 bp with the mgc2-PCR. In chicken samples from farm II, a product of 
approximately 300 bp was amplified. Mgc2 sequence alignment showed that free-ranging birds 
from both farms had the same nucleotide sequence identical to that of chickens from farm I. 
This sequence showed 100% identity with mgc2 sequences of the MG 6/85 vaccine strain. Mgc2 
sequences of chickens from farm II were identical to that of the MG ts-11 strain. A gap of 63 
nucleotides differentiating the two mgc2 sequences was shown (Figure 14). 
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Figure 14: Phylogenetic tree for mgc2 sequences for MG samples from chicken and contacting 
free-ranging birds in relation to MG reference strains using the Clustal-W alignment of MegAlign 
program (DNASTAR Lasergene, Madison, WI). Free-ranging birds from farm I and II and chickens 
from farm I demonstrated identical mgc2 sequence that was 100% homologous to that of the 
MG 6/85 strain. Chickens from farm II showed different mgc2 sequence that was identical to 
that of the MG ts-11 strain. Both mgc2 sequences were different from that of house finches MG 
(HFMG) sequences. 
Sample description: sample entry number (77 for farm I and 331 for farm II)-year of sampling-
bird species (CK = chicken, HS = House sparrow; BT= Blue tits)-genome segment  
MG reference strain description: MS-Reference strain Identity-genome segment (mgc2) 
Description of MG from house finches (HFMG): HFMG-Accession number- segment (mgc2) 
FRB= Free-ranging birds 
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4.2.4. MG typing by MG 16S-23S IGSR sequencing 
With conventional MG 16S-23S IGSR PCR, none of the free-ranging bird samples showed an 
amplicon; however with the newly designed semi-nested MG 16S-23S IGSR PCR, 4 samples from 
free-ranging birds (two from each farm) produced amplicons of about 800 bp. Samples did not 
show size difference on agarose gel electrophoresis. Sequencing of amplified products revealed 
two IGSR sequence types within samples. Similar to the results of mgc2, free-ranging birds from 
both farms together with chickens of farm I showed the same sequence type that was identical 
to the 16S-23S IGSR of MG 6/85 vaccine strain. Chickens from farm II showed different 
sequence type that revealed 98% homology to 16S-23S IGSR of MG-PG31 and MG-R strains 
(Figure 15).  
 
Figure 15: Phylogenetic tree of MG 16S-23S IGSR sequences for MG samples from chicken and 
contacting free-ranging birds and their relation to MG reference strains using the clustal-W 
alignment of MegAlign program (DNASTAR Lasergene, Madison, WI). Free-ranging birds from 
farm I and II and chickens from farm I showed identical MG IGSR sequence type that was 
identical also to the MG 6/85 strain. Chickens from farm II showed different MG IGSR sequence 
type. Both clusters seemed different from HFMG sequences.  
Sample description: sample entry number (77 for farm I and 331 for farm II)-year of sampling-
bird species (CK = chicken, HS = House sparrow; BT= Blue tits)-genome segment  
MG reference strain description: MS-Reference strain Identity-genome segment (IGSR) 
Description of MG from house finches (HFMG): HFMG-Accession number- segment (IGSR) 
FRB= Free-ranging birds 
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4.2.5. MG typing by pvpA sequencing 
With conventional MG pvpA-PCR, no amplicon was produced with samples from free-ranging 
birds; however with semi-nested pvpA-PCR, 4 and 3 samples of free-ranging birds from farm I 
and II, respectively, produced amplicons and were sequenced. With pvpA sequence comparison 
and alignment, two pvpA sequence types were shown within samples. Similar to results of mgc2 
and MG-IGSR, pvpA sequences of free-ranging birds originating from both farms as well as of 
chickens from farm I were identical and corresponded to that of the MG 6/85 strain and the MG 
strain TLS-2 (GenBank accession no. JN113336.1). House sparrow samples 331/HS23/14 and 
331/HS37/14 from the farm II area showed one nucleotide polymorphism in the pvpA sequence 
from other free-ranging birds; however they were still in the same cluster (Figure 16).   
PvpA sequence of chicken samples from farm II showed a different pvpA sequence type that 
was identical to that of MG PG31 strain (Figure 16).  
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Figure 16: Phylogenetic tree for pvpA sequences of MG samples and MG reference strains using 
the clustal-W alignment of MegAlign program (DNASTAR Lasergene, Madison, WI). Free-ranging 
birds from farm I and II and chickens from farm I demonstrated identical pvpA sequence that 
was 100% homologous to the MG 6/85 strain. Chickens from farm II demonstrated different 
pvpA sequence identical to the MG PG-31 strain. Both pvpA sequence types appeared different 
from HFMG sequences. Two house sparrows (331-HS23-14 and 331-HS37-14) showed one 
nucleotide variation from other house sparrows; however they still appear in the sample 
cluster. 
Sample description: sample entry number (77 for farm I and 331 for farm II)-year of sampling-
bird species (CK = chicken, HS = House sparrow; BT= Blue tits)-genome segment  
MG reference strain description: MS-Reference strain Identity-genome segment (pvpA) 
Description of MG from house finches (HFMG): HFMG-Accession number- segment (pvpA) 
FRB= Free-ranging birds 
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4.2.6. Multiple GTS of mgc2/pvpA/MG-IGSR sequencing 
By collecting the sequencing data of three MG genome fragments (mgc2/pvpA/MG-IGSR) 
through multiple GTS analysis, free-ranging birds from both farms areas showed an identical 
circulating MG strain. This strain demonstrated the same mgc2, pvpA, and MG-IGSR sequences 
data like the MG 6/85 strain. Multiple GTS analysis of the three genome segments proved also 
identity between MG of free-ranging birds from both farms and that of chicken from farm I. 
However chicken from farm II had different MG strains that did not show relationship to specific 
MG reference strain. MG strains from chicken in farm II had mgc2 sequences similar to MG ts-11 
vaccine strain, MG IGSR similar to MG PG31 and MG R strain, and pvpA sequences identical to 
MG PG31 strain.  
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4.2.7. MS genotyping by vlhA sequencing 
Nine samples from free-ranging birds (4 from farm I and 5 from farm II) tested positive with the 
newly designed nested vlhA-PCR, however they tested negative with both Jeffery or Wetzel 
conventional vlhA PCRs. Sequencing of amplicons proved two vlhA sequence types within most 
samples from free-ranging birds in both farms; however one sample (331/HS6/14) from farm II 
showed different vlhA sequence type. Chickens from farm I showed two sequence types 
identical to those of the free-ranging birds; whereas chicken from farm II showed only one vlhA 
sequence type in common with the two of free-ranging birds. Each of two house sparrows from 
farm I (77/HS35/14 and 77/HS46/14) produced two vlhA amplicons with two different 
molecular weights on gel electrophoresis. Each amplicon belonged to one of the two vlhA 
sequence types (Figure 17). 
 
Figure 17: Phylogenetic tree for vlhA sequences of MS samples and MS reference strains using 
the clustal-W alignment of MegAlign program (DNASTAR Lasergene, Madison, WI). Free-ranging 
birds from both farms demonstrated two vlhA sequences. Chickens from farm I showed the 
same two vlhA sequences like free-ranging birds; however chickens from farm demonstrated 
only one vlhA sequence identical to the free-ranging birds. Each of house sparrows 77-SP35-14 
and 77-SP46-14 (shown in bold font) from farm I showed two vlhA sequences. 
Sample description: sample entry number (77 for farm I and 331 for farm II)-year of sampling-
bird species (CK = chicken, HS = House sparrow; BT= Blue tits)-genome segment  
MG reference strain description: MS-Reference strain identity-genome segment (vlhA)     
FRB= Free-ranging birds        
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5. Discussion 
5.1. MG and MS incidence and genotyping 
Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are the most relevant 
Mycoplasma species known to infect avian hosts (Kleven, 2008b; OIE, 2008). Massive economic 
losses due to MG/MS infection, expressed in carcass downgrading and condemnation at 
processing, low feed conversion and medication cost, make it as one of the costliest diseases 
confronting poultry industry worldwide (Raviv and Ley, 2013). Definite MG and MS diagnosis 
with pathogen identification down to the subspecies level is essential for tracing the infecting 
pathogen and subsequent evaluation of implemented control strategies.  
Through the first part of the present study, MG infection was confirmed in 26 flocks via species-
specific PCR. However, MG culturing was successful only in 8 from the investigated flocks. MS 
infection was also confirmed in 37 flocks that tested positive with MS species-specific PCR, while 
only 6 MS isolates from them were cultivable.   
Similar results with MG and MS diagnosis have been described in previous studies, where MG-
PCR was more sensitive than culture and tested positive with 65%, while culture was positive 
with only 33% from investigated samples (Kahya et al., 2010). MS-PCR also showed higher 
sensitivity (61% from investigated samples) than culture (25% from investigated samples) in 
natural clinical samples (Marois et al., 2000). However, some studies described comparable 
sensitivity between culture and PCR in experimentally infected chicken (Feberwee et al., 2005b). 
Higher sensitivity results of PCR than culture seems logical as PCR can detect nucleic acid of live 
and dead microorganisms, while culture is only possible with live microorganisms. Furthermore, 
some organisms or isolates are fastidious (like MG and MS) and their cultivation is not often 
successful.  
The nature of the pathogen examined in each case might explain the reason behind this 
difference in sensitivity results between PCR and culture described in these studies. Whereas 
comparable sensitivity between PCR and culture was described with experimental infection 
study in which laboratory cultivable isolates were used (Feberwee et al., 2005b), PCR proved 
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higher sensitivity than culture in the other two studies (Kahya et al., 2010; Marois et al., 2000) 
where natural clinical samples including cultivable and uncultivable isolates were investigated.  
Our results demonstrated also higher incidence of MS (n = 37) than MG (n = 26) in 104 flocks 
investigated. These results conform to recent reports describing an increase in incidence and 
clinical significance of MS in other European countries like Belgium and the Netherlands 
(Haesendonck et al., 2014; Landman, 2014; Michiels et al., 2016). Our results agree partially 
with reports from Germany describing 75% MS incidence by PCR in commercial layers flocks 
while  none of investigated flocks tested positive with  MG PCR (Kohn et al., 2009).  
The current situation and the increase in MS incidence might be due to two reasons; the 
subclinical form known in most MS infection cases (Kleven et al., 1975; Lockaby et al., 1999) as 
well as the implemented control strategies. Many national control programs focus on MG (as 
more clinically relevant avian Mycoplasma) with less strict strategies towards MS control. MS 
control by eradication of infected poultry flocks in many countries, including Germany, is 
applied only to infected breeder and grandparent flocks and does not include layers or broilers 
(Landman, 2014). In some countries where the MS incidence and clinical impact have increased, 
new MS control and eradication strategies including layers have been launched (Landman, 
2014). So that, implementing more strict MS control strategies in Germany seems critical and 
should be considered. 
On the other hand, genotyping methods that offer adequate intra-species discriminatory 
capability are critical for diagnosticians and epidemiologists for tracing infecting pathogens. 
Moreover, expanding usage of live vaccines for control programs in many countries necessitate 
the presence of robust typing methods able to differentiate between vaccine and field strains. 
Concerning MG typing by sequencing through the first part of present study, our results showed 
D-indexes of 0.52, 0.86, 0.94 and 0.95 with the mgc2, MG IGSR, pvpA and the multiple GTS 
(mgc2/pvpA/ MG IGSR) sequencing, respectively. The discriminatory results of single gene 
segments (mgc2, MG IGSR and pvpA) agreed with and supported each other. Starting with mgc2 
sequencing, it was able to differentiate 3 sequence types in MG samples in total (Figure 4). MG-
IGSR showed a better discriminatory power than mgc2 sequencing and could differentiate 10 
sequence types that belonged to 4 main clusters within samples (Figure 5). PvpA sequencing 
agreed with results of mgc2 and MG-IGSR sequencing with an even higher discriminatory power 
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differentiating 14 sequence types into 6 main clusters within samples (Figure 6). Moreover, 
combination of mgc2, MG-IGSR and pvpA sequencing results through a multiple GTS analysis 
proved highest discriminatory power with a good D-index (0.95) and differentiated 18 sequence 
types within MG samples (Table 3). 
Higher D-index than our results has been reported with mgc2, where mgc2 sequencing showed 
a D-index of 0.91 through genotyping of 67 MG isolates from different countries in addition to 
10 MG reference strains (Ferguson et al., 2005). Also MG IGSR sequencing of 38 unrelated MG 
isolates and reference strains should a D-index of 0.95 (Raviv et al., 2007a). However, 
comparable results with pvpA ranged from 0.92 (Ferguson et al., 2005) to 0.97 (Sprygin et al., 
2010a) as well as with multiple GTS (0.97) (Ferguson et al., 2005) have been described. 
Variation in mgc2 discriminatory power between our results and previous reports might be 
explained by the segment of the mgc2 gene investigated. Whereas a segment with a range of 
approximate 230 bp to 300 bp was investigated in the present study, the other study (Ferguson 
et al., 2005) investigated a segment of about 820 bp. Also, the genetic relationship and similarity 
between some of our MG strains (originating from particular geographic locality or even from 
the same farm) which is not the case in the other study (Ferguson et al., 2005) is another 
possible factor for such a difference. This genetic relationship between some of our MG strains 
might also explain our relatively MG IGSR lower discriminatory power (D- index 0.86) compared 
to other reports describing higher D-index of MG IGSR (0.95) (Raviv et al., 2007a) where 
unrelated MG strains were investigated. 
On the other hand, the high D-index of pvpA proved through our study (0.94) and previous 
studies (ranging from 0.92 to 0.97) (Ferguson et al., 2005; Sprygin et al., 2010a) confirm its 
benefit as a single locus sequence target for MG genotyping. Moreover, combination of 
sequencing results from three genome segments (pvpA, MG IGSR, mgc2) showed the highest 
discriminatory power and proved to be a robust typing method capable of intra-species 
differentiation.  
Also through the present study, the pvpA-RFLP discriminated only 6 different genotypes within 
MG samples and showed a D-index of 0.81. Similar pvpA-RFLP results have been also described 
where it could differentiate 7 RFLP groups within 66 MG strains originating from house finch, 
chicken and turkey were examined (Pillai et al., 2003). Results of the pvpA-RFLP were 
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completely in accordance with pvpA sequencing results with superiority of sequencing that 
showed a D-index of 0.94 (Table 4). But with considering the relatively low discriminatory power 
of pvpA-RFLP (0.81) in addition to its laboriousness, time consumption and costs compared to 
sequencing (D-index 0.94), pvpA sequencing (either as a single locus sequencing (SLS) or as part 
of multiple GTS analysis) seems to be more reliable for MG typing and pvpA-RFLP might be more 
suitable where sequencing is not available. 
On the other hand and in order to compare the multiple GTS analysis with the whole genome 
finger printing techniques for MG typing, this was possible with only 8 turkey MG isolates where 
both multiple GTS analysis and the amplified fragment length polymorphism (AFLP) were 
applied. With genotyping of the MG isolates (n = 8) examined by both multiple GTS and AFLP, 
the discriminatory power of multiple GTS (3 GTS types) was slightly lower than that of AFLP (4 
AFLP electrophoretic patterns) (Figure 10 and table 5). Multiple GTS showed identity between 
turkey breeder MG isolate from 2006 (1608-1/11/TK) and the four turkey breeder isolates from 
2011 (1608-3, 4, 5 and 6/11/TK), however AFLP proved the close relationship (not identity) 
between the historical and recent MG isolates. The high discriminatory capability of AFLP (as 
one of the whole genome finger printing techniques) for Mycoplasma typing has been described 
(Feberwee et al., 2005a; Hong et al., 2005a; Hong et al., 2005b).  
The difference between the discriminatory power of multiple GTS and AFLP might be explained 
by the informational content gained by both methods. Whereas AFLP uses information of the 
complete genome, multiple GTS accesses only information of a few genome segments. 
Moreover, the multiple GTS does not depend on cultivated bacteria, unlike the AFLP, and could 
be performed directly from clinical samples. Thus 18 non-cultivable MG pathogens could be 
typed by multiple GTS, while they were not typable by AFLP. Considering this in addition to the 
laboriousness and inability of inter-laboratory data exchange of AFLP compared to the GTS 
(Armour et al., 2013), GTS seems more feasible in practice.  
On the other hand, MG strains investigated through the present study by multiple GTS analysis 
could be differentiated into 4 main clusters; a MG 6/85 like strain cluster, a turkey breeder 
cluster, in addition to two characteristic clusters with no relationship to known MG reference 
strains.  
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The 6/85 like strain cluster included 5 MG isolates. From those, four MG isolates (1608-7/11/TK, 
1608-8/11/TK, 612/13/CK and 77/14/CK) showed identical GTS data like the MG 6/85 vaccine 
strain, while the fifth isolate (1936/12/CK) shared similar (but not identical) sequence data to 
the vaccine strain. These five MG isolates represented nearly 20% of the MG isolates (26 MG 
isolates) found. MG infections and outbreaks with live MG vaccines like strains have been 
reported with MG 6/85, MG ts-11 and MG F like strains (El Gazzar et al., 2011; Gharaibeh et al., 
2011; Kleven et al., 2004; Throne Steinlage et al., 2003). In these studies, the origin of those 
vaccines like MG strains was not always clear whether they originate from vaccine strains or 
from naturally field isolates. This is because some of the infected poultry flocks with vaccines 
like strains had no history with live MG vaccination.  
MG 6/85 like isolates of the present study represented an example for this ambiguity. Whereas 
the MG isolates 1608-7/11/TK and 1608-8/11/TK might originate from MG 6/85 vaccine strain 
because the respective flocks had a history of 6/85 vaccination. This is not the case for isolates 
612/13/CK and 77/14/CK. Such cases of ambiguity constitute a real challenge accompanying 
usage of live MG vaccines and should be considered along with the implementation of 
vaccination strategies. The second cluster (turkey breeder cluster) included one breeder MG 
isolate from 2006 (1608-1/11/TK) and 4 isolates from 2011 (1608-3, 4, 5 and 6/11/TK) 
originating from one turkey farm. This genetic relationship was demonstrated by both the 
multiple GTS analysis and AFLP (Table 4). This close relationship highlights the importance of the 
implementation of strict eradication and control measurements after MG outbreaks. 
Additionally, it illustrates the epidemiological significance of periodical surveillance with 
genotype identification for tracing the origin of infecting pathogens.  
Interesting was also the sample 1561/13/CK that showed a characteristic MG- pvpA sequence of 
an about 770 bp amplicon in size with inclusion of three direct repeat sequences (DRs) in the 
pvpA gene. The MG genome has been documented to contain two copies of DRs in the C-
terminus of the pvpA gene, with the exception of MG F vaccine strain that contains only one 
copy of the DRs (Boguslavsky et al., 2000; Ferguson et al., 2005; Jiang et al., 2009; Liu et al., 
2001; Szczepanek et al., 2010). Also, molecular characterization of the proline-rich C-terminal 
segment of the pvpA gene for some MG strains and isolates proved two direct repeat sequences 
(DR-1 and DR-2) (Boguslavsky et al., 2000). For our knowledge, this is the first report describing 
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three copies of DRs in an MG genome. Further studies on the mechanism of antigenic variability 
of MG are recommended. 
Global comparison of mgc2, MG IGSR and pvpA sequences of MGs of the present study with 
respective gene segments of MGs from other countries demonstrated particularity of German 
MG strains. This comparison illustrated as well the genetic relationship between some Russian 
MG isolates and the German MG 6/85 like isolates (Figures 7, 8 and 9).  
Infection with MG 6/85 vaccine like strains have already been reported in other countries 
(Kleven et al., 2004) where it was not possible to determine exactly if the infecting strain was of 
a vaccine origin or represented a field isolate, which is comparable to our situation in the 
present study. These findings illustrate the epidemiological importance of data exchange 
offered by sequencing and draw our attention to the challenges accompanying usage of live MG 
vaccines for control programs. The establishment of a global data base for MG is in progress 
(Armour et al., 2013) and improvements and international cooperation are highly required. 
However complete sequences of some MG strains have been published (Papazisi et al., 2003; 
Szczepanek et al., 2010), more investigations and comparisons between other MG strains are 
expected due to immediate advances in sequencing technologies and bioinformatics.  
Moving to MS that showed higher incidence than MG. Genotyping of MS strains (n=37) by vlhA 
sequencing revealed circulation of 15 MS strains in German poultry farms with predomination 
of two main MS strains. VlhA sequencing showed a D-index of 0.83 (Figure 11).  
Similar discriminatory power of vlhA gene sequencing have been shown through previous 
studies, where it could differentiate 10 sequence types within 35 MS field isolates in Australia 
(Jeffery et al., 2007), 8 sequence types within 21 Iranian MS isolates (Bayatzadeh et al., 2014), 9 
sequence types within 27 Dutch MS isolates (Dijkman et al., 2014) and 9 sequence types within 
19 Japanese MS isolates (Ogino et al., 2011). 
Concerning the cultivable MS isolates (n = 6) examined by both vlhA sequencing and AFLP, high 
degree of agreement between results of both methods was shown with slightly higher 
discriminatory power of AFLP. Both methods discriminated 3 genogroups within isolates. VlhA 
grouped turkey MS strains (2730/11/TK, 24/12/TK and 187/12/TK) and chicken strain 
2072/11/CK into one sequence type, turkey MS isolate (2141/11/TK) into another type, while 
chicken MS isolate 2081/11/CK represented the third vlhA sequence type (Figure 11). However, 
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genotyping of the MS isolates by AFLP showed also 3 groups (I, II and III) according to their 
electrophoretic pattern, grouping was relatively different from that of the vlhA sequencing. 
Whereas group I included the turkey MS isolates 2730/11/TK, 24/12/TK and 187/12/TK, group II 
included the chicken (2072/11/CK) and turkey (2141/11/TK) MS isolates, and group III in which 
the chicken MS isolate 2081/11/CK was included (Figure 13).  
Comparable results between vlhA sequencing and AFLP have been also described (Dijkman et 
al., 2014), however the slightly higher power of AFLP could be explained by the different 
informational content investigated by both methods. But with considering the non-cultivable 
MS isolates investigated only with vlhA sequencing (n = 31) and the easy data exchange of vlhA 
compared with AFLP and the laboriousness of AFLP, sequencing of the vlhA seems to be more 
applicable. Furthermore, due to the relatively inadequate D-index of vlhA gene (0.83), the 
inclusion of other genome segments seems necessary for better MS typing. Other MS gene 
portions like the 16S-23S intergenic spacer region might allow for better MS strain 
differentiation. 
VlhA sequencing was also helpful and proved 100% homology between MS strains 2730/11/TK, 
24/12/TK and 187/12/TK that originated from three successive outbreaks in a turkey breeder 
farm in the winter of 2011/2012. These strains were different from the MS strain 632/11/TK, 
the causative agent of the preceding outbreak in March 2011. Similarly, vlhA sequencing proved 
the genetic relatedness between the 4 MS strains 833/13/CK, 1233/13/CK, 1372/13/CK and 
331/14/CK that represented 4 successive MS outbreaks appeared in one organic chicken farm. 
Those 4 MS strains, that showed identical vlhA sequence, represented MS outbreaks from 
middle 2013 till the beginning of 2014. The vlhA sequence of these 4 MS strains was different 
from that of the MS strain of previous outbreak (2122/12/CK) occurred in the middle of 2012 in 
the same farm. However the homology of vlhA gene sequence from MS strains originating from 
successive outbreaks seems logic, heterogeneity from preceding strains might be due to 
infection with different MS strains or the same MS strain but with variant vlhA nucleotide 
sequence that has been reported to undergo high antigenic variability (May and Brown, 2011; 
Noormohammadi, 2007; Slavec et al., 2011).  
The global comparison of resulting vlhA sequences demonstrated the genetic relatedness 
between Dutch MS strains and the two predominant MS strains in Germany (Figure 12). This 
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possibility for strain comparison by sequencing represents another advantage of sequencing as 
a typing method offering relatively easier inter-laboratory data exchange. This convergence 
between German and Dutch MS strains might be explained by the geographical proximity, but it 
illustrates as well the epidemiological significance of joint international control strategies.   
Again with the sample 1561/13/CK that generated two vlhA amplicons. These amplicons 
showed different molecular weights in size and nucleotide composition and consequently two 
different sequence types (Figure 11). Obviously this sample originates from a mixed infection 
with two different MS strains. Moreover, this sample represented a MG/MS co-infection. The 
sample showed also a characteristic MG- pvpA sequence (770 bp amplicon) with three DRs in 
the pvpA gene. Although, similarity of some genome fragments caused by horizontal gene 
transfer (HGT) events between MG and MS have been demonstrated through genome 
comparison (Szczepanek et al., 2010; Vasconcelos et al., 2005), no sequence similarity between 
the MG pvpA and MS vlhA gene sequences was reported. So that, inclusion of the characteristic 
MG- pvpA sequence together with the two MS-vlhA amplicons in this sample (1561/13/CK) 
could not be definitely clarified and further investigations should be considered.   
Collectively and based on the results of the first part of the study, we conclude that pvpA gene 
sequencing followed by IGSR showed the best discriminatory power as a single locus sequence 
typing (SLST) method and their combination in the multiple GTS (mgc2/pvpA/MG-IGSR) provides 
good discriminatory power for MG typing. Multiple GTS and vlhA sequencing for MG and MS, 
respectively, allow for intra-species identification as well as global strain comparison and 
consequently for a better understanding of the epidemiology and genetic evolution of 
circulating strains. Furthermore, the increasing MS incidence might require updating of 
implemented control strategies with more strict measures. A broader periodical surveillance 
and stronger international cooperation and coordination for MG/MS control programs should 
be considered. 
5.2. MG and MS in poultry and free-ranging birds 
For long time, MG and MS were thought to be host specific, however reports describing natural 
infections with MG and MS pathogens in new hosts are increasing (Bencina et al., 1987; 
Bozeman et al., 1984; Delaney et al., 2012; Dhondt et al., 1998; Lierz et al., 2000; Morishita et 
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al., 1997). This means that the hypothesis of MG and MS host specificity is difficult to be 
accepted. Also, the actual knowledge concerning the role for non-poultry birds in Mycoplasma 
gallisepticum (MG) and Mycoplasma synoviae (MS) epidemiology is limited and requires more 
investigations. 
So we aimed to investigate the intra-species genetic relationship of MG and MS strains 
originating from infected poultry and their contacting free-ranging birds under complete natural 
conditions. Moreover, based on the discriminatory results of typing methods demonstrated 
through the first part of study, identification of the infecting pathogens down to the sub species 
level was done using multiple GTS analysis of mgc2/pvpA/MG-IGSR (for MG) and vlhA 
sequencing for MS. 
Out of 118 free-ranging birds examined through this part of the study, nucleic acids of MG and 
MS were detected in 16 and 9 birds with 14% and 8% incidence, respectively; however none of 
these MG and MS strains were cultivable. All the birds, that were captured over three days what 
constituted a representative sample for free-ranging birds’ population in areas of infected 
chicken farms, were apparently healthy birds.  
Recent survey reports from Belgium have described MG (0.5%) and MS (1.3%) in free-ranging 
birds, where 5 and 12 out of 890 free-ranging birds tested positive for MG and MS, respectively 
(Michiels et al., 2016). Also through a surveillance study in the USA, 3 out of 358 (0.8%) free-
ranging birds tested positive with MG-PCR and none of investigated birds showed clinical 
manifestations (Farmer et al., 2005). Also the two different studies (Gharaibeh and Hailat, 2011; 
Kleven and Fletcher, 1983), no clinical signs were seen on house sparrows experimentally 
infected with MG.  
The higher incidence for MG and MS in free-ranging birds found in the present study in 
comparison to the Belgian (Michiels et al., 2016) and north American (Farmer et al., 2005) 
studies might be explained by the nature of the samples investigated. Whereas our samples 
were obtained from only two locations with infected chickens with avoidance of double 
sampling the same bird (by marking the samples bird before release), the Belgian and American 
samples were collected from different geographic localities.   
Failure of MG and MS isolation from free-ranging birds might be due to many reasons; the 
nature of sample (oropharyngeal not tracheal), and the fastidious nature of MG and MS, the low 
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susceptibility of free-ranging birds to MG and MS (Dhondt et al., 2008; Kleven and Fletcher, 
1983). Supposing that the free-ranging birds are just mechanical carriers for MG and MS might 
also be a reason for isolation failure. Although pathogen isolation is considered a standard for 
infection diagnosis, the detection of nucleic acids of MG and MS in free-ranging birds suggests 
that these birds are at risk and could play a role for pathogen transmission.  
On the other hand and due to the apparently low MG and MS DNA load in oropharyngeal swabs 
collected from free-ranging birds, we tried to improve the sensitivity of such PCRs by application 
of semi-nested (MG 16S-23S IGSR-PCR and MG pvpA-PCR) and nested (MS vlhA-PCR) PCR 
designs. Semi-nested pvpA-PCR was reported to be 10-fold more sensitive than conventional 
pvpA-PCR (Liu et al., 2001). Although the exact sensitivity degree of the newly designed semi-
nested MG 16S-23S IGSR-PCR and nested MS vlhA-PCR assays was not determined as it was not 
a main aim through the present study, the new PCR assays showed higher sensitivity compared 
to the respective conventional PCRs. The newly designed nested and semi-nested PCRs could to 
a far degree overcome the problem of low detection frequency in samples and 4, 7 and 9 
samples from free-ranging birds  tested positive with the semi-nested MG-16S-23S IGSR PCR, 
semi-nested pvpA PCR and nested MS vlhA PCR, respectively. However, none of these samples 
tested positive with the respective conventional PCR. 
Through MG genotyping by multiple GTS analysis of the mgc2 gene, MG 16S-23S IGSR and the 
pvpA gene, the sequencing results of the 3 segments agreed and supported each other to a far 
distance. Intra-species differences and relationship were firstly shown by mgc2 sequencing. 
These findings were confirmed by sequencing of MG 16S-23S IGSR and pvpA gene and 
subsequently the multiple GTS analysis. Similar results were shown in previous studies 
(Ferguson et al., 2005; Gharaibeh et al., 2011), where sequencing of more than one genome 
segment (multiple GTS analysis) proved to be helpful in explaining the intra-species degree of 
relatedness between MG strains.  
Multiple GTS analysis of MG strains proved the identity of strains originating from free-ranging 
birds’ populations on areas of both farms as well as in chickens of farm I. Surprisingly, this 
circulating MG strain shared the same mgc2, MG 16S-23S IGSR and pvpA sequence data like the 
MG 6/85 vaccine strain. Moreover, this MG strain was found through the first part of the 
present study to be frequent (in 5 out of 26 MG positive samples) in German commercial 
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poultry and backyard flocks. Similar cases of infection with live MG vaccine-like strains like the 
MG 6/85 (Kleven et al., 2004; Throne Steinlage et al., 2003), ts-11 (El Gazzar et al., 2011), and F 
strain (Gharaibeh et al., 2011) vaccines have also been reported. Although the MG 6/85 vaccine 
is used for some MG control programs in German poultry farms, the origin of this 6/85 like 
strain could not be definitely proven because none of both farms had a history of MG 6/85 
strain vaccination. The possibility that the origin of this MG 6/85 like strain either from a nearby 
vaccinated farm or from a field isolate of similar genetic profile to the MG 6/85 vaccine could 
not be definitely clarified. Deeper sequencing analysis for other genome segments might help 
for clarification and differentiation between such closely related strains. Concerning different 
sequence data of MG found in chickens from farm II, it might be due to infection with different 
MG strains or strain competition known to occur between infecting MG strains for replacing 
each other (Turner and Kleven, 1998).  
Similar to MG findings, MS typing demonstrated predomination of two MS lineages in 
populations of free-ranging birds from areas of both farms. Identical vlhA sequences were 
shown in samples of chickens from farm I. However, chickens from farm II showed one MS 
strain identical to the predominating MS strains found in free-ranging birds. Also interesting 
were the two predominating MS strains in free-ranging birds that shared identical vlhA 
sequence data with the two predominant MS strains found in the first part of the study (Figure 
11 and 17). Those two MS strains showed high occurrence in German poultry farms and were 
found in 22 out of 37 MS strains detected (Figure 11). Moreover, these two strains showed also 
identical vlhA sequence with Dutch MS strains (Figure 12).  
On the other hand, each of the samples 77/sp35/14 and 77/sp46/14 showed two different vlhA 
amplicons with two different vlhA sequence types (Figure 17). In a previous in vivo study, 
variations in MS-vlhA gene sequence and MS-vlhA protein have been demonstrated in tracheal 
cultures from the same chicken taken 8 and 18 days post infection (Slavec et al., 2011). Other 
reports described high degree of MS diversity and reversible surface antigenic variation 
(Noormohammadi, 2007; Pflaum et al., 2016). So, explaining the immediate findings by 
presence of two separate MS strains in each bird or in vivo variation of one MS strain could not 
be definitely confirmed or excluded. Moreover, such vlhA variation demonstrated in free-
ranging birds, in addition to pvpA nucleotide variation in house sparrow samples 331/HS23/14 
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and 331/HS37/14 (Figure 16),  might draw attention that these birds could be more than a 
mechanical vehicle for pathogen transmission and might act as a vesicle where antigenic 
changes can occur.  Also, sharing of free-ranging birds in both locations for the same MG and 
MS strains might explain that these birds have their own circulating pathogens, and 
consequently threats of adaptation of these pathogens to new hosts could not be excluded 
(Delaney et al., 2012). 
Based on immediate finding and the genetic relatedness between MG and MS strains 
originating from chicken and contacting free-ranging birds, suitable control measures that 
prevent or minimize this contact should be considered before adaptation of MG, or in particular 
MS, pathogens to a new avian species.  
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6. Summary 
Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are avian pathogens of 
worldwide significant economic impact. Definite diagnosis with pathogen identification down to 
sub-species level represents the first bulwark for correct control approach. Furthermore, the 
role of non-poultry birds in MG and MS epidemiology has not been extensively investigated and 
outbreaks of MG and MS in poultry farms continue to reappear despite implemented control 
measurements. 
The present study includes two parts. Through the first part, 104 German poultry flocks were 
investigated for MG and MS infection and the occurred Mycoplasma spp. were typed and 
compared. MG showed lower incidence and was detected in 26 flocks (25%), however MS was 
identified in 37 flocks (36%).  
MG genotyping was carried out through pvpA-restriction fragment length polymorphism (pvpA-
RFLP) analysis, sequencing of the MG cytadhesin 2 (mgc2) gene, the MG 16S-23S intergenic 
spacer region (IGSR) and the phase-variable protein A (pvpA) gene that showed discrimination 
indexes (D-index) of 0.81, 0.52, 0.86 and 0.94, respectively. Multiple gene-targeted sequencing 
(GTS) analysis of mgc2/pvpA/IGSR discriminated 18 sequence types (from I to XVIII) within MG 
strains and showed the highest D-index (0.95). Multiple GTS revealed a characteristic genetic 
profile of German MG strains that could be differentiated into 4 clusters; a 6/85 like strain, a 
turkey breeder, in addition to two German characteristic clusters with no relationship to known 
MG reference strains.  
MS genotyping was carried out via sequencing of the MS variable lipoprotein and hemagglutinin 
(vlhA) gene that showed a D-index of 0.83. MS genotyping proved circulation of 15 vlhA 
sequence types with predomination of two sequence types. Global comparison of vlhA 
sequences proved genetic relationship between German and Dutch MS strains.  
Results demonstrated also the importance of periodical surveillance for MG and MS with 
species identification down to the strain level. Multiple GTS analysis (for MG) and vlhA 
sequencing (for MS) proved to be dependable, practical genotyping methods capable of intra-
species discrimination that offers also easier inter-laboratory data exchange enabling a better 
understanding of the genetic evolution of circulating pathogens. Increased MS incidence 
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requires updating of implemented control strategies. International cooperation and 
coordination for MG/MS control are epidemiologically very important.   
Through the second part of the study, chicken and contacting free-ranging birds from two 
naturally MG/MS infected chicken farms (I and II) were simultaneously investigated and 
compared for MG and MS. From 118 captured free-ranging birds, DNA of genus Mycoplasma 
was detected in 41 birds. From those, MG-specific and MS-specific DNA were detected in 16 and 
9 samples, respectively. The genetic profile of MG was compared through multiple gene-
targeted sequencing (GTS) analysis of mgc2, pvpA and MG IGSR. Free-ranging birds from both 
farms’ areas as well as chickens of farm I showed the same MG lineage that shared identical GTS 
profile like MG 6/85 vaccine strain. MG of chickens from farm II demonstrated a different GTS 
profile. The genetic profile of MS was investigated through sequencing of the MS vlhA gene. 
Free-ranging birds captured on both farms showed two circulating MS lineages which were also 
detected in chickens of farm I. However, chickens from farm II had only one MS strain in 
common with free-ranging birds.  
In conclusion, results of the present study demonstrate the importance of periodical 
surveillance for MG and MS. Multiple GTS analysis (for MG) and vlhA sequencing (for MS) 
proved to be robust, practical genotyping methods capable of intra-species discrimination. 
Sequencing allows also for easier data exchange between laboratories and consequently a more 
comprehensive understanding of the genetic relationship of internationally circulating strains. 
Increased MS occurrence necessitates updating of the immediate control strategies. Stronger 
international cooperation and coordination for MG/MS control are recommended.   
Moreover, results highlight also the possibility of an epidemiological role played by free-ranging 
birds, especially the wide spread house sparrows, in MG and MS spread between poultry farms. 
Hence, suitable control measures to decrease the contact between poultry and free-ranging 
birds should be quickly launched. 
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7. Zusammenfassung 
Title: Epidemiologische und genetische Studien zu Mycoplasma gallisepticum und Mycoplasma 
synoviae bei Geflügel und frei lebenden Vögeln 
Mycoplasma gallisepticum (MG) und Mycoplasma synoviae (MS) sind vogelpathogene Bakterien 
mit weltweit bedeutenden wirtschaftlichen Auswirkungen. Die genaue Diagnose mit der 
Pathogenidentifizierung bis zum Unterartenniveau ist die Basis für entsprechende 
Kontrollmaßnahmen. Außerdem ist die Rolle von frei lebenden Vögeln  in der MG- und MS-
Epidemiologie noch nicht umfassend untersucht worden und Ausbrüche von MG und MS in 
Geflügelfarmen treten weiterhin auf, trotz durchgeführter Kontrollmaßnahmen. 
Die vorliegende Studie umfasst zwei Teile. Im ersten Teil wurden 104 Geflügelherden in 
Deutschland auf MG und MS untersucht, und die nachgewiesenen Mykoplasmen typisiert und 
miteinander sowie mit der Literatur verglichen. MS zeigte ein häufigeres  Vorkommen und 
wurde in 37 (36%), MG dagegen nur in 26 (25%) Herden entdeckt.  
Es wurde eine MG-Genotypisierung durch pvpA-Restriction Fragment Length Polymorphism 
(pvpA-RFLP) Analyse, Sequenzierung des MG Cytadhesin 2 (mgc2)-Gens, MG-16-23 Intergenic 
Spacer Region (IGSR) und MG Phase-Variable Protein A (pvpA)-Gens durchgeführt. Diese 
Untersuchungen ergaben Discrimination Indices (D-Index) von 0,81, 0,52, 0,86 und 0,94. Die 
multiple gene-targeted sequencing (GTS) Analyse der mgc2/pvpA/IGSR-Gene ergab 18 
Sequenztypen (von I bis XVIII) mit dem höchsten D-Index (0.95). Die multiple GTS zeigte ein 
charakteristisches genetisches Profil der deutschen MGs, die in 4 Cluster unterschieden werden 
konnten; ein MG 6/85-ähnliches Cluster, ein Puteneltern- Cluster, und zusätzlich zwei deutsche 
charakteristische Cluster ohne Beziehung zu bekannten MG-Referenzstämmen.  
Die MS-Genotypisierung wurde durch Sequenzanalyse des MS-Variable Lipoprotein und 
Hemagglutinin (vlhA)-Gens untersucht, welches einen D-Index von 0,83 aufwies. Die MS-
Genotypisierung zeigte 15 vlhA-typen mit einer besonderen Häufigkeit von zwei Typen. Der 
Vergleich des gesamten vlhA- Gens mit in der GenBank hinterlegten Sequenzen zeigte  
genetische Beziehungen zwischen deutschen und holländischen MS- Sequenzen auf. 
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Im zweiten Teil der Studie wurden Hühner und frei lebende Vögel von zwei natürlichen MG/MS 
infizierten Hühnerfarmen (I und II) gleichzeitig beprobt, und auf MG und MS untersucht, sowie 
gefundene Sequenzen genotypisiert. Von 118 gefangenen frei lebenden Vögeln wurde DNA der 
Klasse Mycoplasma in 41 Vögeln entdeckt. Von diesen 41 positiven Tieren wiesen 16  MG-
spezifische und 9 MS-spezifische DNA auf. Das genetische Profil von MG wurde durch eine 
Multiple GTS Analyse der folgenden Gene mgc2, pvpA und MG IGSR verglichen. Frei lebende 
Vögel aus beiden Farmen sowie Hühner der Farm I wiesen identische MG-Genotypen auf, die 
auch identisch mit dem GTS-Profil des MG 6/85 Impfstammes war. Das GTS-Profil von MG der 
Hühner von Farm II war jedoch unterschiedlich. Das genetische Profil von MS wurde durch eine 
MS-vlhA-Sequenzierung untersucht. Frei lebende Vögel auf beiden Farmen wiesen zwei 
zirkulierende MS-Typen auf, die auch in Hühnern der Farm I entdeckt wurden. Jedoch hatten 
Hühner von der Farm II nur einen MS-Typ gemeinsam mit der frei lebenden Vögeln derselben 
Farm.  
Die Ergebnisse der vorliegenden Studie unterstreichen die Wichtigkeit der regelmäßigen 
Untersuchung von Geflügelbetrieben auf MG und MS sowie die genaue Analyse der 
Stammvorkommen. Multiple GTS-analyse (für MG) und vlhA-sequenzierung (für MS) haben sich 
als praktische Genotypisierungsmethoden zur Differenzierung innerhalb der jeweiligen Spezies 
erwiesen.  Die Sequenzierung bietet auch die Möglichkeit zum Datenaustausch zwischen 
Laboren. Das hohere Vorkommen von MS sollte zur Aktualisierung der Kontrollstrategien dieses 
Erregers in Geflügelbetrieben führen. Verstärkte internationale Zusammenarbeit und 
Koordination für die Kontrolle von MG/MS werden empfohlen.   
Außerdem unterstreichen die Ergebnisse eine epidemiologische Rolle der frei lebenden Vögel, 
besonders der Haussperlinge, bei der MG- und MS-Übertragung zwischen Geflügelfarmen. 
Geeignete Kontrollmaßen für solche Vögel sollten in Betracht gezogen werden. 
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